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 Abstract  
 
Background: This review examined the validity of reading tests in estimating 
premorbid intelligence in people with dementia. The literature is highly 
contradictory, with some studies suggesting reading ability is well preserved 
and others documenting changes even in the early stages of dementia. 
 
Main Objectives: To establish whether: 
1) reading tests provide similar estimates of IQ to other estimators in people 
with a dementia; and 
2) people with dementia differ significantly from matched controls on reading 
tests and other estimators of premorbid intelligence. 
 
Data sources: Medline, PsychINFO, CINAHL, Scopus and The Cochrane 
Library were searched and limited to papers written in English and to Adults (18 
years+). Search terms included “dement*”, and “reading test*”. Titles and 
abstracts were examined and reference lists of the included studies were 
checked to identify further papers. 
 
Study eligibility criteria, participants and interventions: Eligibility included 
studies which compared a reading-based test against a VIQ measure and/or a 
demographic regression equation, in people with a dementia.  
 
Study appraisal and synthesis methods: The Strobe checklist was used to 
rate the methodological quality of the eighteen identified papers, along with an 
additional checklist of items pertinent to this field. Quantitative results of 
fourteen papers were compared using effect sizes. 
 
Results: Different IQ estimators produce similar estimates in people with mild 
dementia, and there is no difference between people with mild dementia and 
healthy individuals on reading tests. However, with increasing severity of 
dementia, differences begin to emerge.  
 
Limitations: The main methodological issues were a lack of reporting of 
educational levels and dementia severity levels, and differing terms for 
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dementia severity. Differences in study designs meant effect sizes could not be 
combined across studies for analysis. 
 
Conclusions:  Reading tests are a valid estimator of premorbid intelligence in 
mild or questionable cases of dementia. 
 
Implications of key findings: A score of ≥ 20 on the MMSE would indicate that 
a reading test can be used with relative confidence. 
 
Key words:   dementia, reading test
 10 
Introduction 
The assessment of dementia and determining whether a person meets a 
particular set of diagnostic criteria uniformly requires there to be a decline in 
cognitive functioning. There is wide variability in cognitive performance in the 
general population, and thus it may prove difficult to compare an individual 
against group norms and especially so for those who are only mildly impaired. 
Therefore it may be more relevant to compare an individual’s current level of 
functioning against their previous baseline. Such baselines are rarely available 
and the clinician must instead rely on methods that estimate premorbid 
intelligence. Three of the most researched approaches to estimating premorbid 
ability are reading tests, “hold” versus “don’t hold” tests and demographic 
regression equations.  
 
Reading tests 
Reading tests became popular as a premorbid estimator of intelligence with the 
emergence of research suggesting that reading and intelligence are highly 
correlated (e.g. Willshire, Kinsella, & Prior, 1991). Such tests assess knowledge 
obtained prior to the onset of a neurological disease (Nelson & O’Connell, 1978) 
and which is relatively well preserved compared to other domains such as 
memory and praxis. Typically these tests are normed against the most recent 
version of the Wechsler Adult Intelligence Scale (WAIS) to provide estimated 
Full Scale Intelligence (FSIQ), which can then be compared with obtained 
(current) IQ scores. A significant discrepancy between predicted and obtained 
IQ scores indicates cognitive decline. 
 
Various tests have been developed including the National Adult Reading Test 
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 (NART), the Wechsler Test of Adult Reading (WTAR), the reading subtest of 
various versions of the Wide Range Achievement Test (WRAT, WRAT-R and 
WRAT-3), the ‘Spot the Word’ test (STW) and the Schonell Graded Word 
Reading Test (SGWRT). Full references for all tests in this review are presented 
in Appendix 1.7. 
 
Most of these tests consist of irregularly-spelled words which the individual is 
asked to read aloud. The irregular grapheme-to-phoneme translations (such as 
the “gh” in the word bough) in the words make pronunciation difficult if standard 
spelling rules are applied, and thus previous familiarity is required in order to 
provide a correct answer.  
 
The current evidence base is highly contradictory with respect to whether 
reading tests are affected by dementia. Some studies suggest that the NART 
(e.g. Crawford, Parker & Besson, 1988), STW (e.g. Yuspeh & Vanderploeg, 
2000), and the WRAT (e.g. Johnstone, Callahan, Kapila, & Bouman, 1996) 
perform well in estimating premorbid IQ in people with dementia. The original 
validation study for the WTAR reported it to be superior to demographic 
regression equations (Wechsler, 2001) and there is a similar picture for the Test 
of Premorbid Functioning (TOPF; Wechsler, 2011). Other research suggests 
the NART (e.g. McFarlane, Welch & Rodgers, 2006), STW (e.g. Law & 
O’Carroll, 1998) and WTAR (e.g. McFarlane et al., 2006) are affected with 
increasing severity of dementia. 
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Some conditions preclude the use of these reading tests such as visual acuity 
difficulties (e.g. Crawford et al., 1989) and people with language difficulties (e.g. 
Stebbins, Gilley, Wilson, Bernard & Fox, 1990) or whose first language is not 
English. Several studies concluded that reading tests are unsuitable for patients 
with moderate/severe dementias (e.g. Patterson, Graham & Hodges, 1994), 
suggesting that reading becomes compromised in the later stages of dementia. 
Additionally, reading tests may systematically underestimate and overestimate 
IQ for the higher and lower IQ ranges (e.g. Johnstone et al., 1996), respectively. 
Finally, as healthy individuals show wide variation in their performance across 
different cognitive domains (e.g. Taylor & Heaton, 2001), it raises doubt as to 
whether general intellectual functioning can truly be measured by one 
apparently “spared” cognitive domain. 
 
“Hold” versus “don’t hold” tests 
One alternative to reading tests is the comparison of “hold” (e.g. Vocabulary) 
versus “no-hold” (e.g. Block Design) WAIS subtests, a method based on the 
premise that some over-learned verbal skills are preserved in the mild to 
moderate dementias. Different versions of the WAIS utilise different terminology 
for groups of subtests measuring verbal and perceptual abilities. As most of the 
studies in this review include older versions of the WAIS, the older terminology 
of Verbal IQ (VIQ) and Performance IQ (PIQ) will be used.  
 
Given that both reading tests and VIQ subtests measure verbal skills, it is 
unsurprising that they are generally well correlated (Strauss, Sherman & 
Spreen, 2006). However, some research purports that reading tests are a better 
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predictor of intelligence than VIQ subtests (e.g. Sharpe & O’Carroll, 1991) and 
that even the best “hold” tests are not impervious to the effects of a dementia 
(e.g. Hart, Smith & Swash, 1986). 
 
Demographic regression equations 
Another alternative to reading tests is the use of demographic regression 
equations, which draw on the well-established relationship between 
demographic variables and intelligence (Hodges, 2007). Such factors, e.g. age 
and years of education, are regressed against a measure of current intelligence 
such as the WAIS (Crawford & Allan, 1997).  
 
Different studies have reported varying degrees of predicted variance. Crawford 
and Allan (1997) reported that occupation, age and years of education 
accounted for 53%, 53%, and 32% of the variance in FSIQ, VIQ, and PIQ, 
respectively. Barona, Reynolds and Chastain (1984) reported that education, 
race, and occupation were the most powerful predictors of premorbid WAIS-R 
IQ although their regression equation only accounted for 36%, 38% and 24% of 
WAIS-R FSIQ, VIQ and PIQ, respectively. 
 
Demographic equations have the advantage of being unaffected by cognitive 
decline, due to their reliance on static factors, or suboptimal effort on tests.  
Nevertheless, self-reported factors such as years of education are open to 
inaccuracy in the cognitively impaired individual. Eppinger, Craig, Adams and 
Parsons (1987) noted that one cannot differentiate between an undergraduate 
and postgraduate degree, nor between mainstream and special education. 
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Additionally, the degree of error associated with these types of variables is 
considerable (Basso, Bornstein, Roper & McCoy 2000), and very large 
confidence interval ranges can result in almost meaningless estimations unless 
the individual has experienced a very large degree of decline. Furthermore, this 
approach is also affected by regression to the mean (Basso et al., 2000).  
 
Accuracy is limited in all approaches to estimating IQ, as surmised by Griffin, 
Mindt, Rankin, Ritchie and Scott (2002) who, in a comparison of methods for 
predicting IQ, reported reading tests and demographic equations systematically 
under or over-estimated IQ.   
 
The evidence base for the accuracy of reading tests does not provide the 
clinician any considerable confidence with respect to whether or not they are a 
valid tool for this purpose and will be the focus of this review. 
 
Aims and objectives 
In order to determine how effective reading tests are in establishing premorbid 
intelligence in people with a dementia, reading test-estimated IQs will be 
compared with other IQ estimators, namely demographic regression equations 
and/or tests which provide a measure of VIQ.  
 
The review objectives were to establish whether: 
1) there is any difference between a reading test-predicted IQ and obtained IQ 
scores in people free from neurological disease; 
 15 
2)  reading tests provide similar estimates of IQ to other estimators in people 
with a dementia; and 
3) people with dementia differ significantly from matched controls on reading 
tests and other estimators of premorbid intelligence. 
 
Method 
Search strategy 
The following electronic bibliographic databases were searched between 
February and May 2015 (final search date 24/05/2015): Medline, PsychINFO, 
CINAHL, Scopus and The Cochrane Library. The search was limited to papers 
written in English and to Adults (18 years+).  
 
Databases were searched using various search terms, including: “dement*”, 
“pre?morbid intell*” and “reading test*” (see Appendix 1.2 for full strategy). Titles 
and abstracts were examined to identify articles featuring a reading-based test 
and a comparator (i.e. VIQ and/or a demographic equation). The following 
journals were hand searched: British Journal of Clinical Psychology and Journal 
of the International Neuropsychological Society. Reference lists of included 
studies were checked to identify further relevant papers. 
 
Inclusion and exclusion criteria 
The titles and abstracts of papers identified as comparing a reading-based test 
with another IQ estimator in people with a dementia were screened against the 
following inclusion and exclusion criteria. 
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Inclusion Criteria: 
 Studies comparing the performance of a reading test (in estimating 
premorbid intelligence) against a measure of VIQ and/or a demographic 
regression equation; and 
 Studies which included a dementia group comprising Alzheimer’s, 
vascular or a mixed presentation dementia (studies may or may not have 
also had a control group).  
 
Exclusion Criteria: 
 Studies that were not in English; 
 Studies that investigated translated versions of a reading test; 
 Studies in which dementia patients were indiscriminately grouped with 
other neurological/psychiatric disorders (e.g. Parkinson’s disease) and 
results analysed as such; 
 Studies that compared only the performance of reading tests; 
 Studies which did not specify which reading test was utilised; and 
 Studies which developed regression equation(s) to predict premorbid 
functioning using error scores of reading tests and other factors (e.g. 
demographic variables). 
 
For papers where it was unclear as to whether they should be 
included/excluded, discussions were held with the research supervisor to 
determine this. 
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Assessment of methodological quality 
To rate the methodological quality of the included studies the STROBE checklist 
(von Elm et al., 2007) was adapted i.e. items were removed from the checklist 
which were not relevant to this study, such as translating estimates of relative 
risk into absolute risk. To account for methodological issues pertinent to this 
review, such as risk of bias if demographic variables were not reported and 
analysed, an additional checklist was developed (see Appendix 1.3 for a copy of 
the full checklist). All papers were rated by the author and a second rater 
assessed 50% of the studies as a means of examining the inter-rater reliability 
of the checklist; there was 97% agreement and discrepancies were resolved 
through discussion. 
 
Assessment of bias 
The quality checklist credited points to studies for accounting for biases such as 
appropriate analysis of demographic variables. The quantitative results also 
considered biases such as methods of classifying disease severity. 
 
Summary measures and synthesis of results 
Summary measures were primarily difference in means (Cohen’s d). Three 
studies reported correlation coefficients (r) which were considered separately. 
Effect sizes could not be combined due to differences in study designs.   
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Results 
Figure 1 contains a flow diagram depicting the number of studies included and 
excluded at each stage of the search. References of included studies are 
included in the ‘References’ section and excluded studies are in appendix 1.4. 
Figure 1: Flowchart of systematic search strategy 
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(n = 1 ) 
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(n =422) 
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(n =14) 
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Eighteen studies were initially considered as to the assessment of 
methodological quality, based on the checklist. Fourteen studies were then 
investigated for differences between IQ estimators and relationships between 
them; effect sizes could not be calculated for four papers due to insufficient 
reporting of statistics. Study characteristics and demographic details are 
presented in Appendix 1.5. 
 
Part 1: Quality assessment 
Diagnostic criteria 
Diagnostic accuracy in studies is necessary due to the differing brain 
pathologies, disease progression and cognitive profiles of the various dementia 
subtypes. A range of diagnostic guidelines/criteria, laboratory tests, 
psychometric tests, and functional and structural imaging techniques are 
available in the diagnosis of dementia. 
 
Ten of the studies in this review used criteria developed by the National 
Institute of Neurological and Communicative Disorders and Stroke (NINCDS) 
and the Alzheimer’s Disease and Related Disorders Association (ADRDA) 
(McKhann et al., 1984).  
 
Of the remaining eight studies, two utilised diagnostic manuals (DSM and ICD); 
three used and specified a range of tests such as scans and psychometric 
testing; and three did not give details of how a diagnosis was made.   
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The accuracy of dementia diagnosis in the studies included in this review is 
high, with only three studies failing to report how a diagnosis was made. 
 
Dementia subtypes 
Eight studies included patients with Alzheimer’s disease, five included a 
“dementia” group (unspecified subtypes), and another five had various subtypes 
specified. Diagnostic guidelines for differentiating subtypes included guidelines 
such as the ICD and NINCDS/ADRDA. All of the studies with various subtypes 
grouped patients together as a heterogeneous ‘dementia’ group rather than 
analysing the results separately. Five studies in this review included a dementia 
group with no specified dementia subtypes.  
 
Severity of dementia 
It is widely accepted that reading ability in dementia is compromised with 
increasing severity of the disease (Lezac, Howieson, Bigler, & Tranel, 2012) 
and, as such, one would expect studies investigating reading tests to take 
account of this.  
 
Seven of the eighteen studies in this review made no attempt to classify level of 
severity within the “dementia” group. One of the studies cited the use of 
NINCDS/ADRDA criteria and another used the Dementia Rating Scale (DRS; 
Mattis, 1988) which Shay et al. (1991) reported was a reasonable estimator of 
dementia when using a cut-off score of 136; however score ranges for severity 
levels have not been researched.  
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Five papers used Mini Mental State Examination (MMSE) cut-off scores to 
classify severity levels as “mild”, “moderate” and “severe”. Seven studies in this 
review made no attempt to classify severity and another two (making up half of 
the studies in total) provided very little information about how severity was 
categorised. The remaining 50% used instruments which have been researched 
with regards to categories of severity. 
 
Control groups 
In order to ensure a control group is indeed free from neurodegenerative 
disease, or other conditions which might impact on testing such as head injury, 
psychiatric disorder etc, screening should be undertaken. One of the most 
reliable methods is the use of a validated instrument such as the MMSE. 
Interviews can also be undertaken to rule out psychiatric or neurological 
disorders but for an objective and comprehensive screen, a validated tool 
should be incorporated into the interview (Meyer et al., 2001).  
 
In the ten studies which had a control group, none used both a validated 
instrument and a clinical interview. 6/10 studies used a screening interview and 
only 4/10 used a validated screening tool (MMSE or DRS). 
 
Inclusion / exclusion criteria 
Of the ten studies which contained both a patient group and a control group, 
only two specified inclusion and exclusion for both groups and five studies did 
not detail any inclusion or exclusion criteria for either group. 
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Eight studies contained a dementia group only; one specified criteria for the 
patient group and seven did not detail any criteria.  
 
67% of all studies in this review did not contain any reference to inclusion and 
exclusion criteria. Thus the reliability and reproducibility of these studies is 
highly questionable.  
 
Demographic variables 
Demographic variables have a significant association with intelligence and 
require to be controlled for in studies investigating premorbid intelligence, either 
through using matched controls or else using appropriate statistical tests. 
 
Five of the eighteen studies used matched controls. All of these matched for 
age, four also matched for gender and years of education (YoE); two of these 
four also included occupational status and one also included race. Three of 
these five studies also performed statistical analysis on demographic variables.  
 
Six studies without matched groups performed statistical analysis on 
demographic variables. Two of these analysed age, one analysed age and YoE, 
two analysed age, gender and YoE, and one explored age, gender, YoE and 
social class.  
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Part 2: Quantitative analysis 
Studies included in the analyses below are in order of methodological strength 
(see ‘References’) and statistical significance (p) is included when reported.  
 
1) Is there any difference between a reading test-predicted IQ and 
obtained IQ scores in people free from neurological disease? 
Eight studies were included which had a healthy group, a reading test-estimated 
IQ and an obtained IQ (i.e. WAIS FSIQ or VIQ). Three studies explored the 
difference between these measures (Table 1), and three studies (Table 2) 
considered the relationship between them. Where effect sizes could not be 
calculated, the raw data from these studies is included in Table 1 and marked 
with *. Positive effect sizes (d) reflect a higher reading test IQ than the 
comparator and the opposite is true for negative values.  
 
Of the three studies exploring differences, two studies (#3 and #5) found either 
no effect or only a small difference between predicted and obtained IQ. One 
study (#10) used two versions of the WRAT and this indicated a moderate 
difference; however there was no such difference found for the NART. 
 
In visually comparing the raw data from the studies (#8 and #9) where effect 
sizes could not be calculated, there appeared to be only negligible differences 
between reading-estimated and WAIS IQs.  
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Table 1: Differences between reading test-predicted and obtained IQ scores in 
healthy participants 
 
Table key: NART(-R) = National Adult Reading Test(-Revised); WRAT(-R;-3) =  Wide Range 
Achievement Test(-Revised; -3rd Edition); FSIQ = Full Scale intelligence; VIQ = verbal 
intelligence; WAIS(-R) = Wechsler Adult Intelligence Scale(-Revised); WAIS Vocab = WAIS 
vocabulary subtest 
 
 
Table 2: Relationships between reading test-predicted and obtained IQ scores in 
healthy participants  
 
Study # Reading test(s) Comparator (r) (p) 
2 MHT NART .62  
17 SGWRT WAIS FSIQ .74  
18  
SGWRT 
WAIS FSIQ .75 < .001 
VIQ .78 < .001 
WAIS Vocab .79 < .001 
Table key: MHT = Moray House Test; SGWRT = Schonell Graded Word Reading Test; NART 
= National Adult Reading Test; WAIS = Wechsler Adult Intelligence Scale; FSIQ = full scale 
intelligence; VIQ = verbal intelligence; WAIS Vocab = WAIS vocabulary subtest 
 
All three studies in Table 2 found a strong positive association between reading 
test scores and obtained IQ scores in healthy participants.  
 
 
Study # Reading test(s) Comparator (d) 
3 NART VIQ WAIS-R VIQ -0.06 
NART FSIQ WAIS-R FSIQ -0.32 
5  
NART FSIQ 
WAIS FSIQ 0.02 
WAIS VIQ 0.04 
WAIS Vocab 0.15 
8* NART FSIQ 
(mean 106.5) 
WAIS Vocab 
(mean 106.7) 
 
9* NART FSIQ 
(mean 108.8) 
WAIS FSIQ 
(mean 109.4) 
 
NART-R FSIQ 
(mean 102.5) 
WAIS-R FSIQ 
(mean 101.8) 
 
10 NART-R  
WAIS-R 
-0.14 
WRAT-R -0.45 
WRAT-3 -0.53 
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Overall, it seems that there are no significant differences between reading 
test-predicted IQ and obtained IQ scores in people free from neurological 
disease, and there is a strong positive correlation between the two. 
 
2)  Do reading tests provide similar estimates of IQ to other estimators in 
people with a dementia? 
Eleven studies were included for analysis; eight explore differences between 
reading tests and another method of estimating premorbid IQ (Table 3), and  
three investigated the relationship between these measures (Table 4). Positive 
effect sizes (d) reflect a higher reading test-estimated IQ than the comparator 
and the opposite is true for negative values. Effect sizes could not be calculated 
for seven studies. Five of these (studies marked with *) have been included in 
Table 3, and the test results included. The remaining two (#17 and #18) did not 
report results which could be interpreted. 
 
Reading tests vs. VIQ 
In studies investigating differences between reading tests and a measure of 
VIQ, reading tests provided a higher IQ estimate, with nearly all of the studies 
finding a large effect size. Most of these studies did not classify severity of 
dementia; the one that did (#3) reported a higher reading test IQ for both mild 
and moderate dementia groups.  
 
Three studies explored the strength of association between the NART and a 
measure of VIQ (Moray House Test; MHT and Mill Hill Vocabularly Scale; 
MHVS); two of these (#2 and #15) found a large association and the final one 
(#12), a follow up study a year later (to #15), found a medium relationship. Both 
 26 
of the dementia groups in the former two studies were reportedly mild-moderate 
severity; it is likely that a year later (#12) the participants had deteriorated and 
we might expect this to affect the relationship between the measures.  
Table 3: Differences between reading test-estimated IQ and other estimators in 
people with a dementia      
Study 
# 
Reading 
test(s) 
Comparator Groups p (d) 
(mean group IQ 
scores) 
1* NART(-)  
 
Demo Equation 
Minimal AD .96  
Mild AD .042  
CCRT(-) Minimal AD .78  
Mild AD .38  
3  
NART 
VIQ Mild AD  1.67 
Mod AD  1.58 
Demo Equation Mild AD  0.12 
Mod AD  -0.61 
4* NART  Minimal AD (mean 107.0) 
Mild AD (mean 101.5) 
Mod AD (mean 92.4) 
 Demo Equation Minimal AD (mean 104.4) 
Mild AD (mean 107.7) 
Mod AD (mean 106.2) 
5 NART VIQ  
 
AD 
<.01 1.77 
WAIS Vocab <.05 0.86 
SGWRT VIQ <.01 1.23 
WAIS Vocab  0.25 
6*  
NART 
 V. Mild dementia (mean 108.7) 
Mild dementia (mean 104.5) 
Mod/Sev dementia (mean 99.1) 
  
Demo Equation 
V. Mild dementia (mean 115.0) 
Mild dementia (mean 114.7) 
Mod/Sev dementia (mean 113.5) 
7* NART  Mild AD (mean 106) 
Mod AD (mean 101) 
Sev AD (mean 99) 
 WAIS Vocab 
(raw scores) 
Mild AD (mean 47.7) 
Mod AD (mean 40.6) 
Sev AD (mean 31.1) 
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Table key: NART(-R) = National Adult Reading Test(-Revised); NAART = North Amercia Adult 
Reading Test; WRAT(-R;-3) = Wide Range Achievement Test(-Revised; 3rd edition); SGWRT – 
Schonell Graded Word Reading Test; Demo Equation(-R) = demographic regression equation(-
Revised); WAIS Vocab = Wechsler Adult Intelligence Scale vocabulary test; VIQ = verbal 
intelligence; AD = Alzheimer’s disease; Mod = moderate; (sig.) = significant result; (n.s.) = not 
significant result 
 
 
 
Table 4: Relationships between reading test-estimated IQ and other estimators in 
people with a dementia      
Study 
# 
Reading 
test(s) 
Comparator Groups p (r) 
2 NART MHT AD  0.63 
12 NART MHVS Dementia (n.s.) 0.30 
15 NART MHVS Dementia <.01 0.69 
Table key: NART = National Adult Reading Test; MHT = Moray House Test; MHVS = Mill Hill 
Vocabulary Scale; AD = Alzheimer’s disease; (n.s.) = not significant 
8*  
 
NART 
 
 
WAIS Vocab  
AD (mean NART = 
104.0, mean Vocab 
= 97.3) (sig.) 
VD (mean NART = 
97.8, mean Vocab 
= 102.0) (n.s.) 
9 NART Demo Equation  
AD 
<.01 -1.12 
NART-R Demo 
Equation-R 
<.05 -1.04 
10 WRAT-R  
 
Demo Equation 
Mild AD 
Mod AD 
 -0.23 
-0.77 
WRAT-3 Mild AD 
Mod AD 
 -0.17 
-0.64 
NART-R Mild AD 
Mod AD 
 0.23 
-0.38 
11  
 
NART 
 
 
Demo Equation 
Dementia (No 
Language issue) 
 -1.25 
Dementia (naming 
or fluency issue) 
 -1.07 
Dementia (naming 
and fluency issue) 
 -1.86 
13 NART Time 1 VIQ Time 1 Dementia (total 
group) 
<.000 0.71 
NART Time 2 VIQ Time 2 <.000 0.97 
NART Time 1 VIQ Time 1 Dementia 
(subgroup of total) 
(n.s.) (0.25) 
NART Time 3 VIQ Time 3 <.002 0.95 
14 WRAT-R VIQ AD  0.22 
NAART  0.49 
16 NART Demo Equation Dementia  -0.63 
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Study #2 obtained the MHT scores when the cohort of participants were 
children and this study lends significant support for the NART as a premorbid 
estimator of intelligence, as the strength of the relationship was strong for these 
participants who as adults had a mild/moderate dementia. 
 
Reading tests vs. demographic regression equations 
The results of this analysis are considered in terms of papers that categorised 
dementia into severity levels and those which did not (see Appendix 1.5). The 
two papers (#9 and #16) which did not categorise severity levels reported a 
higher demographic regression equation-estimated IQ and the effect sizes were 
medium to large.  
 
Of the three studies which did classify severity, two (#3 and #10) found no 
difference between reading and demographic IQ estimates in people with a 
“mild” dementia (MMSE score 20-25; DRS score 110-130), and one (#11) found 
a large difference (MMSE 16-23). This latter study, however, did not report the 
educational level of the participants and the MMSE score would suggest they 
were more impaired than participants in the other studies. Studies #3 and #10 
included a “moderate” severity dementia group and both found a medium to 
large difference between reading and demographic IQ estimates. 
 
For the five studies where effect sizes could not be calculated, significant 
differences between reading and demographic IQ scores were reported for 
three studies with a “mild” dementia group (MMSE scores 14-23, 14-23 and 16-
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23); two of which also reported a difference in a “moderate” dementia group 
(MMSE scores 2-13 and 5-15); and one of which found no difference for a 
“minimal” group (MMSE 24-28). The final study did not categorise severity but 
reported a difference between the two estimators in people with a dementia. 
 
The results suggest that reading tests and demographic equations provide 
similar results for people with a “mild” dementia but the question of what 
constitutes a “mild” dementia is problematic. Reading tests provide a higher 
estimate of IQ compared to measures of VIQ, although in “mild” dementias 
there is a positive correlation between the two. Significant differences begin to 
emerge on all measures for people with increasing severity of dementia. Many 
studies did not categorise severity levels and thus their results are difficult to 
interpret. The issue of severity is considered further in this review. 
 
3) Do people with dementia differ significantly from matched controls on 
reading tests and other estimators of premorbid intelligence? 
This question was investigated using seven studies which had a control and 
dementia group and the results are presented in Table 5. The raw data of two 
studies (*) was included for visual inspection purposes. Information is also given 
on whether the control groups were matched or statistical analysis revealed any 
differences between them and people with a dementia. Where control groups 
were matched to patients, this is indicated by (M). Positive effect sizes (d) 
reflect a higher IQ for controls than for people with a dementia and the opposite 
is true for negative values. Although many more studies will have explicitly 
investigated the use of VIQ measures and demographic equations in estimating 
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premorbid IQ, these measures have been included from the studies in this 
review to act as a comparator against reading tests. 
 
Reading tests  
Studies #1, #3 and #10 (all matched on age and years of education) found 
differing effect sizes for their minimal, mild and moderate dementia groups. 
Studies #1 and #10 utilised similar score ranges on the MMSE but labelled 
them differently (see Appendix 1.5). If we therefore compare the studies on 
MMSE scores 14-19 and 14-23, both found a medium-large effect size between 
matched controls and dementia groups; and for MMSE scores 24-28 and 20-25 
both found no difference or only a small difference. The “moderate” group 
(DRS<110) in study #3 also found a large effect size between groups and only 
a small effect size for the “mild” group (DRS 110-130).  
 
 
Furthermore, study #2, which compared the NART against an actual obtained 
IQ from childhood, reported a non-significant effect between mild/moderate  
dementia and healthy controls, when the scores were adjusted for the MHT 
score (due to there being differences between the groups in terms of childhood 
ability). This study also analysed results for people (n = 14) with an MMSE 
score of <21 and the correlation for MHT-NART was a medium/strong 
relationship of 0.71.  
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Table 5: Comparison between controls and people with a dementia on different 
IQ estimators 
Study 
# 
Reading 
test(s) 
VIQ or 
Demo 
Equation 
Groups Matched? p (d) 
(mean group IQ 
scores) 
1 
 
 
 
NART   
C vs. Mild AD 
 
 
 
 
(M) 
<.05 -0.87 
CCRT <.05 -0.59 
WTAR <.05 -0.54 
STW >.05  (-0.28) 
NART   
C vs. Minimal 
AD 
<.05 -0.07 
CCRT >.05  (-0.06) 
WTAR >.05  (-0.09) 
STW >.05  (0.01) 
2 NART MHT C vs. dementia No diff in 
age 
<.001 0.67 
MHT(Adj.) .12 (n.s.) (0.27) 
3 
 
 
 
NART  C vs. Mild AD  
 
 
(M) 
 
C vs. AD 
<.005 
0.27 
C vs. Mod AD 1.11 
 VIQ C vs. Mild AD C vs. AD 
<.005 
1.86 
C vs. Mod AD 2.75 
Demo 
Equation 
C vs. Mild AD C vs. AD 
>.005  
(0.41) 
C vs. Mod AD (0.54) 
5 NART   
C vs. AD 
Comparable 
on social 
class & 
occupation 
<.05 0.79 
 VIQ <.001 1.72 
WAIS 
Vocab 
<.01 1.04 
6*  
 
NART 
 C   
 
Controls 
selected to 
match 
patient 
groups on 
Demo – 
estimated 
IQs 
(mean 111.0) 
V. Mild 
dementia  
(mean 108.7) 
 
Mild dementia  (mean 104.5) 
Mod/Sev 
dementia  
(mean 99.1) 
 Demo 
Equation 
C (mean 114.9) 
V. Mild 
dementia 
(mean 115.0) 
Mild dementia (mean 114.7) 
Mod/Sev 
dementia 
 
 
 
(mean 113.5) 
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Table key: NART(-R) = National Adult Reading Test(-Revised); CCRT = Cambridge Contextual 
Reading Test; WTAR = Wechsler Test of Adult Reading; STW = Spot the Word test; SGWRT = 
Schonell Graded Word Reading Test; WRAT(-R;-3) = Wide Range Achievement Test(-Revised; 
3rd edition); MHT(-Adj.) = Moray House Test(-adjusted scores); Demo Equation = demographic 
regression equation; WAIS = Wechsler Adult Intelligence Scale; VIQ = verbal intelligence; WAIS 
vocab = WAIS vocabulary subtest; AD = Alzheimer’s disease; Mod = moderate; (M) = matched 
groups; (n.s.) = not significant 
 
 
Study #5 found a large difference between controls and patients on the NART 
and which recorded severity level to be mild-moderate based on Blessed, 
Tomlinson and Roth’s (1968) 37-item test; however there was no information on 
the comparability of the two groups on age, years of education or gender. Two 
studies (#17 and #18) found no difference between healthy controls and people 
9* NART  C vs. AD  
(M) 
(mean C = 106.1, 
mean AD = 104.0) 
(n.s.) 
C vs. VD (mean C = 97.8, 
mean VD = 103.0) 
(n.s.) 
 WAIS 
Vocab 
C vs. AD (mean C = 107.0, 
mean AD = 97.3) 
(sig.) 
C vs. VD (mean C = 107.0, 
mean VD = 102.0) 
(sig.) 
10 WRAT-R  C vs. Mild AD  
 
 
No 
difference in 
age or 
education 
 
 0.13 
C vs. Mod AD 0.45 
WRAT-3 C vs. Mild AD  -0.01 
C vs. Mod AD 0.25 
NART-R C vs. Mild AD  0.17 
C vs. Mod AD 0.59 
 Demo 
Equation 
C vs. Mild AD  0.36 
C vs. Mod AD 0.22 
17 SGWRT  C vs. dementia Not 
considered 
 0.13 
 VIQ  1.57 
18 SGRWT  C vs. dementia No 
difference in 
age 
 
(n.s.) (-0.01) 
 VIQ <.001 1.08 
WAIS 
Vocab 
<.01 0.57 
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with a dementia on the SGWRT, however one did not consider any differences 
in demographic characteristics of the group and the other only considered age. 
Furthermore, severity levels were not reported.  
 
Overall, there appears to be no significant difference between “mild” dementia 
and controls on reading-test estimated IQs, when “mild” is categorised as a 
score of >20 on the MMSE. Although the study (#2) which included an actual IQ 
score suggested that the NART is still valid in people with an MMSE score of 
<21, this was based on a small sample and other studies suggest that 
significant differences begin to emerge.  
 
 VIQ 
All studies in the analysis found a difference on measures of VIQ between 
controls and people with a dementia, with effect sizes ranging from medium to 
large. Only study #3 had a matched control group, one (#17) made no 
consideration of demographic variables, and the rest reported some 
demographic variables. It would appear that VIQ is affected by dementia. 
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Discussion 
Much of the research on reading tests as an estimator of IQ has focused on 
how well such tests work in people with a dementia, and whether such tests 
hold in the face of increasing dementia severity. In practice, individuals with 
more moderate and severe dementias rarely require formal neuropsychological 
assessment, as evidence of cognitive decline is more acutely apparent. For 
individuals with a mild or questionable dementia, neuropsychological 
assessment is recommended by NICE (2006). Generally, however, the 
evidence for the validity of reading tests in the assessment of dementia has 
been conflicting and is the subject of this review. 
 
In considering the results of this review, it is important to be cognisant of the 
age of the papers included, with fourteen of the eighteen studies at least fifteen 
years old. Reporting standards have changed considerably and thus whilst it 
may be necessary to be cautious when interpreting the results of some studies, 
it is not to suggest they are methodologically unsound; instead it is noted that 
they did not report certain information. The main methodological issues 
affecting the review were a lack of reporting of educational levels and dementia 
severity levels, lack of dementia subtype classification, and differing terms for 
dementia severity.  
 
The issue of severity is important because if some of the studies included in this 
review recruited people with a moderate-severe dementia, we would expect a 
decline in reading score. Education also impacts on reading ability and some 
research tentatively suggests that people who develop a dementia have lower 
levels of intellectual functioning and levels of education. Whalley, Starr, 
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Athawes, Hunter, Pattie and Deary (2000) examined data from the 1932 
Scottish birth cohort (where children were given IQ tests aged 11). They 
concluded that mental ability scores were significantly lower in children who 
developed a dementia as older adults compared with those who did not. 
As education and severity both impact on reading ability, the results of some 
studies in this review should be interpreted cautiously.  
 
With regards to classifying dementia subtypes, research in differentiating 
cognitive profiles of Alzheimer’s and vascular dementia has evidenced that oral 
word reading ability is comparable between the two (e.g. Vuorinen, Laine & 
Rinne, 2000) and a recent systematic review by Mathias and Burke (2009) 
reported that none of the tests of verbal ability (including WAIS subtests and 
reading), or general intellectual functioning (FSIQ, VIQ or PIQ) discriminated 
Alzheimer’s from vascular dementia. The indistinct cognitive profiles of these 
two diseases suggest it is not essential to analyse results by diagnostic 
categories of these two dementias in particular. 
 
Some studies, however, included a dementia group with no specified dementia 
subtypes. This is problematic as subtypes other than Alzheimer’s and vascular 
dementia may have different cognitive profiles which may impact on the results. 
For example, in a systematic review of Alzheimer’s and frontotemporal 
dementia, Hutchinson and Mathias (2007) reported differences between the 
subtypes on VIQ scores, WAIS subtests, and a large difference on the MMSE, 
which suggests that some dementia subtypes should be analysed separately. 
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The quality of reporting and methodological issues highlighted suggest that 
further research is required in this field in order to provide up-to-date and robust 
evidence regarding the validity of reading tests in estimating premorbid 
intelligence in people with a dementia.  The conclusions of the analyses in this 
review are based on the available evidence to date and are detailed below. 
 
In people free from neurological disease, reading tests are a generally good 
predictor of IQ. Of particular interest is the study comparing a MHT score 
obtained when the participants were aged 11 and a NART score obtained from 
the same participants in adulthood. This study reported a medium strength 
association between the two measures, suggesting the NART is a good 
predictor of IQ. This result is perhaps unsurprising, given that the MHT is a 
measure of verbal ability as is the NART. Nevertheless, the findings of this 
study are also supported by most of the other studies suggesting no difference 
(or only a small difference) between reading tests and current measures of IQ in 
healthy individuals. 
 
In people with a “mild” dementia, there appears to be little difference between 
the different methods in IQ estimation. As dementia severity increases, VIQ-
estimated IQs are lower than reading test equivalents, and reading tests provide 
lower IQ estimates than demographic equations. We would expect there to be a 
difference for more impaired individuals between reading test IQs and 
demographically-based IQs, as reading ability becomes compromised with 
increasing severity; however it appears VIQ measures are the least robust 
measure in assessing IQ in people with moderate/severe dementias. 
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One significant finding from this review is the problematic use of terms such as 
“mild” and “moderate”, even when utilising a validated tool for the purposes of 
classifying severity. The MMSE is one tool often used to make this distinction. 
Various researchers (e.g. Patterson et al., 1994) have explored MMSE score 
ranges for severity levels, resulting in different category boundaries being 
reported. Therefore, the terms “mild”, “moderate” and “severe” are not easily 
comparable across studies as, for example, in one study scores between 14 
and 19 constituted a “moderate” severity whilst in another study scores between 
14 and 23 represented a “mild” severity. Furthermore, these category 
boundaries are problematic as more recent research has suggested that the 
MMSE is highly susceptible to the effects of education, age and socioeconomic 
status (Hodges, 2007). Although these issues mean categorising dementia 
severity level is challenging, there is still value in attempting to do this, as score 
ranges on validated tools enable a comparison of the dementia severity levels 
of participants in different studies. 
 
It may be more meaningful to consider when it may be appropriate to use 
reading tests based on a cut-off score on the MMSE, which this review would 
suggest ≥ 20. Although the study with an actual IQ obtained from childhood 
suggested that even below a score of 21 the NART was still a valid tool, other 
studies suggest that compromised reading ability means reading tests provide 
lower estimates of IQ.  Demographic equations provide a higher IQ estimation 
and therefore may be a more accurate estimate, providing caution is exercised 
for individuals at the higher and lower end of the ability scale. 
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In conclusion, reading tests are a valid estimator of premorbid intelligence in 
people with a dementia, whose scores are ≥ 20 on the MMSE.  
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PLAIN ENGLISH SUMMARY 
 
Introduction 
The early detection of a dementia, such as Alzheimer’s or vascular dementia, is 
becoming increasingly important as advances are made in terms of medication 
and therapy, and research suggests that early intervention may be beneficial 
(The National Audit Office, 2007). For people with a mild or questionable 
dementia, it is recommended that that they have access to cognitive testing as 
part of a wider assessment (NICE, 2006, p.21).  
 
Cognitive testing aims to identify whether there has been a deterioration in a 
person’s general level of functioning. To do this, a Psychologist will try to 
determine how well an individual was functioning before a dementia began 
(their “premorbid” functioning) and then compare this with tests which assess 
the person’s current level of functioning. If there is a difference between these, 
this may indicate the presence of a dementia. 
 
To estimate premorbid functioning, Psychologists can use a reading test or a 
mathematical equation which calculates a person’s age, level of education (etc). 
Reading ability is not thought to be affected by a dementia until the disease 
becomes more severe. 
 
Aims and objectives 
A new reading test to estimate premorbid functioning, called the “Test of 
Premorbid Functioning” (TOPF), was released in 2011 and as yet there have 
been no independent studies exploring how well this estimates premorbid 
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functioning in people with a dementia. This was the aim of the current study. In 
order to achieve this, the TOPF was compared with a different reading test 
(Spot-the-Word 2; STW-2) and a mathematical equation (as described above). 
The main questions to answer were:  
1) Does the TOPF provide a similar estimate of premorbid functioning for 
people with a dementia compared to people without a dementia? 
2) How well does the TOPF compare with the STW-2 and the mathematical 
equation in estimating premorbid functioning in people with a dementia? 
 
Methods and participants 
Thirty people with a diagnosis of dementia (Alzheimer’s, vascular or both) and 
their partners (who did not have a dementia) were recruited from two NHS 
clinics. The partners were recruited to provide a comparison against people with 
a dementia, and were similar in age and socioeconomic status. All participants 
were tested on the TOPF, STW-2 and details were recorded for the 
mathematical equation (e.g. years of education).  
 
Results 
1) From this study, it appears the TOPF under-estimated premorbid 
functioning in people with a dementia, although it was a relatively small 
under-estimation. 
2) The TOPF and STW-2 provided similar estimates of premorbid 
functioning in people with a dementia, and both were an underestimation. 
The mathematical equation provided a higher estimate of functioning 
than the reading tests.  
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Conclusion 
This study found that the TOPF under-estimated premorbid functioning in 
people with a dementia compared with healthy individuals, although this was a 
small under-estimation. Other studies have reported some similar results. 
Limitations of the study included a modest sample size and the mathematical 
equation used was an old equation and may not be directly comparable with the 
reading tests (it may have over-estimated premorbid functioning). Future 
research could include a similar larger scale study. If Psychologists continue to 
use the TOPF, they should interpret the results cautiously and use other tests 
as well as information from the patient. 
 
Key references 
National Audit Office (2007). Improving services and support for people with 
dementia. London: The Stationery Office. Retrieved [21st April 2015] from: 
http://www.nao.org.uk/wp-content/uploads/2007/07/0607604.pdf 
 
National Institute for Health and Clinical Excellence (NICE) (2006). Dementia: 
Supporting people with dementia and their carers in health and social care. 
National Institute for Health and Clinical Excellence. Retrieved [2nd May 2015] 
from: https://www.nice.org.uk/guidance/cg42. 
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Abstract 
Introduction: The Test of Premorbid Functioning (TOPF) is a relatively new 
reading test designed to estimate premorbid intelligence in people with a 
diagnosed or suspected dementia. A discrepancy between premorbid and 
current functioning is indicative of cognitive decline. Previous studies have 
reported mixed results on the validity of reading tests in people with dementia, 
and the TOPF has yet to be investigated as to how well it holds in dementia. 
 
Objectives: To assess the robustness of the TOPF against the Spot-the-Word 
(version 2; STW-2)  and a demographic regression equation in estimating 
premorbid ability in people with Alzheimer’s disease (AD), vascular dementia 
(VD) and mixed dementias (AVD). 
 
Design: A cross-sectional study with two groups of participants assessed on 
three measures of premorbid ability.  
 
Methods: Thirty patients with an ICD-10 diagnosis of probable AD, VD or ADV 
were recruited from two NHS Older Adult Community Mental Health teams and 
their scores on the TOPF, STW-2 and a demographic equation were compared 
with thirty healthy matched controls.  
 
Results: Significant between-group differences were found for both the TOPF 
and STW-2, with an average difference of 5-7 IQ points and a medium effect 
size. The results suggest that both reading tests systematically under-estimated 
premorbid IQ in the dementia group. The demographic equation provided a 
significantly higher estimation of IQ than both of the reading tests for people 
with a dementia. When the dementia group was arbitrarily split into a “less 
impaired” and “more impaired” group, based on the median ACE-III score of 65, 
there was still a medium effect size between the healthy controls and the 
dementia groups on the TOPF and STW-2.  
 
Conclusion: The findings of this study suggest that the TOPF underestimates 
premorbid IQ in people with a dementia. Clinicians should exercise caution 
when interpreting the results of reading tests by considering and reporting the 
confidence intervals for obtained-minus-predicted IQ discrepancies and with 
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clear reference to the clinical history and other cognitive test results. These 
findings are discussed with respect to the literature on the validity of reading 
tests and recommendations for future research are provided. Limitations of the 
study included a modest sample size and the use of a demographic equation 
which has not been normed against the current WAIS-IV. 
 
Practitioner points: 
1) The TOPF and STW-2 provide similar estimates of premorbid IQ in 
people with a dementia. 
2) Both reading tests systematically underestimated premorbid ability in 
people with a dementia, by between 5 and 7 IQ points.  
3) When using reading tests to determine an obtained-minus-predicted 
discrepancy score, confidence intervals should be considered and 
reported in the analysis and there should be clear reference to the 
clinical history and other cognitive test results. 
4) This study was based on a modest sample size and utilised a 
demographic equation which has not been normed against the current 
WAIS-IV. 
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Introduction  
The early detection of a neurodegenerative disease, such as Alzheimer’s, is 
becoming increasingly important as advances are made in pharmacological and 
psychological treatments and research suggests that early intervention may be 
beneficial (The National Audit Office, 2007). Alzheimer’s disease is the most 
common type of dementia, with the National Audit Office estimating that 62% of 
diagnosed dementias are of the Alzheimer’s type, with vascular dementias 
accounting for around 30%. 
NICE (2006) states that an assessment of a person with suspected dementia 
should be comprehensive and include history taking, a medication review and 
cognitive, physical and mental examination; and that “formal neuropsychological 
testing should form part of the assessment in cases of mild or questionable 
dementia” (p.21).  
Estimation of premorbid intelligence is a well established and crucial component 
of neuropsychological assessment, due to the need to establish a baseline from 
which to identify any cognitive decline. Currently, the three main approaches to 
estimating premorbid intelligence are demographic-based regression equations, 
lexical decision-making tasks and reading ability.  
Reading tasks have become popular in clinical practice and utilise vocabulary 
level as a correlate to intelligence (IQ). Such tests rely on the resistance of 
reading ability to cognitive impairment associated with early stages of most 
neurodegenerative conditions. 
The participant is presented with irregularly spelled words and prompted to 
pronounce each one. The irregular grapheme-to-phoneme translations (such as 
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the “gh” in the word rough) in the words make it difficult to pronounce without 
previous familiarity. Since participants cannot apply standard pronunciation 
rules to complete the task, their vocabulary can be assessed by their ability to 
pronounce the irregularly spelled words, and by extension, estimate their 
premorbid IQ. However, reading tests are not impervious to the effects of 
degenerative disease and several studies (e.g. Cockburn, Keene, Hope & 
Smith, 2000) have demonstrated that reading ability becomes compromised 
with increasing dementia severity. 
Lexical decision tasks measure the ability to classify stimuli (a string of letters) 
as words or non-words. The “Spot The Word” test (Baddeley, Emslie, & Nimmo, 
1992) is one such task which research (e.g. Yuspeh & Vanderploeg, 2000) 
suggests is resistant to cognitive impairment and thus provides a useful 
alternative to reading tests for estimating premorbid intellectual functioning. 
However, this test also appears to significantly decrease in accuracy with 
moderate to severe dementias (e.g. Law & O’Carroll, 1998).There is now a 
second version of this test (STW-2; Baddeley & Crawford, 2012) in which 
participants are presented with pairs of words, one of which is real and the other 
a nonsense word. Participants select the real word from the pair and there is no 
requirement for the word to be pronounced. This task allows decisions to be 
made through multiple methods including; meaning, familiarity, appearance and 
sound of words and participants are not penalised for incorrect pronunciation.  
Demographic regression equations employ an actuarial approach to the 
estimation of premorbid ability, using known relationships between demographic 
variables and performance on intelligence testing. Variables such as age, 
education and occupation are entered into a regression formula to yield a 
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predicted "IQ" score. One advantage of utilising this method is that an estimate 
is obtained without the need for testing and is independent of the person’s 
current cognitive functioning, thus remaining constant throughout an individual’s 
lifespan. However, some studies (e.g. Rentz et al., 2004) have demonstrated 
indices such as education are not always the most accurate estimation of IQ, 
perhaps as they do not account for intellectual development that may continue 
throughout life. There are also concerns regarding the accuracy of self-
reporting. 
Accuracy is limited in all approaches, as shown by Griffin, Mindt, Rankin, 
Ritchie, and Scott (2002) who, in a comparison of methods for predicting IQ, 
reported that reading tests and demographic equations systematically under or 
over-estimated IQ. These limitations pose significant challenges for clinicians 
who require accurate estimations in order to assess the extent of cognitive 
decline in patients with a dementia. Research in this area continues in order to 
equip clinicians with the best available evidence regarding the relative strengths 
and weaknesses of individual and combined approaches and regarding new 
tests available. 
Although reading ability has been demonstrated to be preserved in the early 
stages of dementia (e.g. McGurn et al., 2004), McFarlane, Welch and Rodgers 
(2006) found a demographic estimation (based on a regression equation) and a 
lexical decision-making task (“Spot the Word” test) provided a higher estimate 
than the National Adult Reading Test (NART) for participants with mild 
Alzheimer’s disease.  The study also found that the Wechsler Test of Adult 
Reading (WTAR; Wechsler, 2001) was more robust than the NART, however it 
did underestimate IQ in participants with mild Alzheimer’s. 
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The Test of Premorbid Functioning (TOPF) was developed by Wechsler in 2011 
and is an updated version of the WTAR. The TOPF is standardised with the 
Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV; Wechsler, 2008). As 
the TOPF is a relatively new test there has yet to be any study conducted to 
assess its performance as a reading test against the other forms of estimating 
premorbid intelligence levels.  
 
Aims and hypotheses  
 
The principle aim of this study is to provide a follow-up to McFarlane et al.’s 
(2006) study, exploring the robustness of the relatively new TOPF against 
another reading-based test (Spot the Word version 2; STW-2) and a 
demographic estimate (based on a regression equation). The TOPF is the 
primary focus of this study as it is currently the most routinely used reading test 
in clinical practice. The TOPF will be explored in the context of Alzheimer’s 
dementia (AD), Vascular dementia (VD) and mixed Alzheimer’s and Vascular 
dementia (AVD). As it is well documented (e.g. Taylor, 1999; Cockburn et al., 
2000) that reading ability becomes compromised with increasing severity of 
dementia, the study will focus on those with mild/moderate dementias. 
 
In order to assess the robustness of the TOPF, the reading test-estimated IQ 
scores for people with a dementia will be compared against a matched healthy 
control group, and the three IQ estimators will be compared against one another 
between and within the two groups of participants. 
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The primary hypothesis for this study is: 
1) Participants with a dementia will have significantly lower estimated IQs 
on a reading test of pre-morbid ability (TOPF) than matched healthy 
controls. 
Secondary hypotheses are: 
2) Participants with a dementia will have significantly lower estimated IQs 
on the TOPF than STW-2; 
3) There will be no more than a medium effect size difference between the 
IQ estimates for participants with a dementia compared with the healthy 
control group on the STW-2; and 
4) The discrepancy between a demographic based estimate of pre-morbid 
IQ and estimates derived from tests of reading ability will be significantly 
greater for those with dementia than healthy controls.  
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Method 
Study design 
This was a cross-sectional study with two groups of participants assessed on 
three measures of premorbid ability. One group was a healthy control group, the 
other group was comprised of individuals with a diagnosis of dementia. 
 
Ethics approval 
This study was reviewed and given favourable opinion by the West of Scotland 
Ethics Committee in December 2014. The study proposal can be found in 
Appendix 2.2 and a copy of the Ethics approval letter in Appendix 2.3.  
 
Participants 
Patients with a diagnosis of probable Alzheimer’s (AD), vascular (VD) or mixed 
Alzheimer’s/vascular dementia (AVD) were recruited from two NHS Greater 
Glasgow and Clyde Older Adult Community Mental Health Teams (CMHTs) 
between February 2015 and July 2015. The diagnosis of a dementia was made 
by a psychiatrist using the ICD-10 criteria. Controls were recruited from the 
partners of patients to provide a match for age and socio-economic status.  
 
Fifty-six patients within the CMHTs were identified by NHS staff as meeting the 
inclusion criteria and who had a partner. Of those identified, thirty were recruited 
to the study, twelve declined to participate, two could not be contacted, six were 
inappropriate referrals (e.g. ACE-III score was too high) and, when contacted by 
the researcher, five were too physically unwell and one had died. 
 
All participants were administered the Addenbrooke’s Cognitive Examination-III 
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(ACE-III) to screen for cognitive impairment. All participants in the dementia 
group were required as part of the inclusion criteria to have an ACE-III score of 
≤75 and all controls were ≥88 (see ‘Measures’ for explanation). Other inclusion 
criteria included individuals up to the age of 84, as this is the maximum age for 
the STW-2 normative data (the TOPF being 89). Exclusion criteria included 
individuals with visual or auditory difficulties (which couldn’t be corrected with 
the use of glasses or hearing aids); a history of stroke, a diagnosed or 
suspected learning difficulty such as dyslexia; expressive aphasias; current or 
previous serious psychiatric disorder; those whose first language was not 
English; and those individuals with other types of dementia.  
 
Justification of sample size 
The sample size was based on a power calculation for an independent t-test, as 
this was the planned main method for statistical analysis. McFarlane et al.’s 
(2006) study found a medium effect size on reading tests between their 
‘minimal’ and ‘mild’ dementia groups. For the current study, a medium effect 
size would provide clinically meaningful information about the utility of reading 
tests in estimating premorbid intelligence. Therefore, a G*Power 3.010 (Faul, 
Erdfelder, Lang, & Buchner, 2007) calculation was computed to determine the 
number of participants required to achieve a medium effect size, using the 
values: p = 0.05 and power = 0.8. This calculation suggested a minimum of 36 
participants per group was required. 
 
Measures 
The ACE-III copyright is held by Professor John Hughes and has been validated 
as a cognitive screening tool for Alzheimer’s disease (Hsieh, Schubert, Hoon, 
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Mioshi, & Hodges, 2013). Cut-off scores of 88 and 82 (out of a possible 100) 
indicate a potential cognitive decline. A score of ≤75 was selected as the cut-off 
for people with a dementia due to a systematic review by Crawford, Whitnall, 
Robertson and Evans (2012), where ACE scores of ≤75 were likely to identify 
people as highly probable to have a dementia, with high sensitivity and 
specificity amongst people being assessed in memory clinics for possible 
dementia. The ACE-III was administered according to the test instructions 
(http://www.neura.edu.au/frontier/research/tests-download/) to determine the 
cognitive status of all participants.  
 
The TOPF and STW-2 were administered according to the published test 
manual and instructions. Both the TOPF (Wechsler, 2011) and STW-2 
(Baddeley & Crawford, 2012) have been validated and normed against the 
WAIS-IV. Participants were asked to read aloud the 70 TOPF words (unless 
they scored 0 on five consecutive items; in which case the test was 
discontinued) and to either read aloud or point to the correct word from 100 
word-pairs on the STW-2. The order of administration of the TOPF and STW-2 
was counterbalanced as they contain a small number of words which are the 
same or similar and were never administered immediately after one another. 
The ACE-III was completed in-between. This was to reduce the potential risk of 
practice effects on a few items. 
 
The demographic equation used was Crawford and Allan’s (1997), which 
provides an estimated WAIS-R (Wechsler, 1981). FSIQ estimate and which was 
compared against scores on the TOPF and STW-2. The demographic equation 
was: 
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Predicted FSIQ = 87.14 – (5.21 x occupation) + (1.78 x years of education) + 
(0.18 x age) 
In line with the regression equation, “occupation” was classified into 5 
categories: 1 = professional; 2 = intermediate; 3 = skilled; 4 = semi-skilled; and 
5 = unskilled. Individuals who were retired, unemployed or who were 
housewives/husbands were categorised according to their previous occupation. 
Those who had never worked were classified as unskilled (code 5). Participants 
were credited with 0.5 years of education for every year of part-time education 
they had undertaken which was leading to a qualification, as detailed by 
Crawford and Allan (1997). Occupation was classified according to the Office of 
Population Censuses and Surveys (1980). 
 
Updated regression equations have not been published to convert 
demographic-estimated IQs to the newer normative samples of the WAIS-IV, 
however Crawford and Allan’s (1997) equation was utilised in McFarlane et al.’s 
(2006) study.  
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Results 
Preliminary analyses 
Demographic details for participants were analysed for the two groups and are 
presented in Table 6 below. The diagnoses (and percentage of the entire 
dementia group) of the dementia group were: AD=15 (50%), VD=8 (27%) and 
AVD=7 (23%). Results were not analysed separately by diagnosis as this would 
have reduced power and research suggests that tests of verbal ability (such as 
reading) and general intellectual functioning (IQ) are not able to discriminate 
Alzheimer’s disease from vascular dementia (Mathias & Burke, 2009).  
 
Table 6: Demographic details of participants by group 
 
There were no significant differences between the groups on any of the 
demographic variables, with the exception of mean ACE-III scores (t (58) = 
12.690, p < .0001), which was expected. 
 
 
 Controls 
(n = 30) 
Dementia 
(n = 30) 
Stats p value 
Gender 
Male 
Female 
 
17 
13 
 
13 
17 
 
X² = .067 
 
p = .796 
Age (in years) 
Mean 
(SD) 
 
75.33 
(7.1) 
 
75.80 
(6.5) 
 
t = -.267 
 
p = .791  
Education (in years) 
Mean 
(SD) 
 
11.79 
(3.1) 
 
11.06 
(2.7) 
 
t = .990 
 
p = .326 
ACE-III (max score = 100) 
Mean 
(SD) 
 
92.37 
(3.3) 
 
60.2 
(13.5) 
 
t = 12.69 
 
p < .0001 
Occupational class 
(Number in each group) 
1 
2 
3 
4 
5 
 
 
2 
10 
14 
4 
0 
 
 
2 
7 
18 
3 
0 
 
 
 
X² = 1.344 
(Fisher’s Exact 
Test) 
 
 
 
p = .826 
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Data integrity 
All data were visually screened for outliers. There were missing data for the 
STW-2 test for three participants in the dementia group and one participant in 
the control group - testing on the STW-2 was abandoned for two participants in  
the dementia group who were becoming distressed by the task; the other 
participant in this group and the one healthy individual refused to complete the 
measure. 
 
Distribution 
Assumptions of normality were investigated using histograms, box plots and 
Shapiro-Wilks tests. Box plots, as seen in Figure 2, revealed outliers on all 
measures; however inspection of the means, 5% trimmed means and medians 
revealed that these outliers did not impact significantly on the results. Shapiro-
Wilks tests established that the assumption of normality was violated for both 
groups on the demographic equation, and for the dementia group on the TOPF.  
 
Figure 2: Box plots for IQ scores, by estimator and group 
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Transformation of the data did not alter the distribution of scores and, therefore, 
the issue of non-normality was resolved with the use of non-parametric tests to 
analyse results for the TOPF and demographic equation. As the results for 
STW-2 in both groups were normally distributed, parametric tests were utilised 
for this test. 
 
Data analysis 
A combination of parametric and non-parametric tests was used to compare the 
two groups on the three measures of IQ. The independent variable was 
diagnosis i.e. healthy control or a diagnosis of dementia. The dependent 
variable was the premorbid IQ score. All hypotheses were tested at p < .05.  
 
Main hypotheses 
The means (M), standard deviations (SD), medians (Md) and inter quartile 
ranges (IQR) for each group on TOPF, STW-2 and the demographic equation 
are presented in Table 7.  
 
Table 7: Descriptive statistics for IQ measures by group  
 TOPF IQ STW-2 IQ Demo IQ 
Control (n = 30) 
M 
SD 
Md 
IQR 
 
104.13 
11.3 
101.0 
97.0 – 111.0 
 
102.76 
8.8 
102.0 
95.8 – 107.8 
 
107.59 
8.6 
105.83 
101.9 – 111.4 
Dementia (n = 30) 
M 
SD 
Md 
IQR 
 
97.90 
8.5 
96.0 
93.0 – 102.0 
 
96.81 
7.8 
98.0 
90.8 – 99.8 
 
106.03 
7.7 
103.71 
101.9 – 107.5 
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Hypothesis 1: Participants with a dementia will have significantly lower 
estimated IQs on a reading test of pre-morbid ability (TOPF) than healthy 
controls. 
A Mann-Whitney U test revealed a significant difference on the TOPF between 
people with a dementia (Md = 96.0, n = 30) and matched healthy controls (Md = 
101.0, n = 30; U = 266.5, z = -2.816, p = .007, r = .36). Therefore, the first 
hypothesis was confirmed, with a medium effect size.  
 
Hypothesis 2: Participants with a dementia will have significantly lower 
estimated IQs on the TOPF than STW-2. 
A Wilcoxon Signed Rank test revealed a non-significant difference between the 
TOPF (Md = 96, n = 30) and STW-2 (Md = 98.0, n = 27; z = -1.411, p = .15, r = 
.29) for people with a dementia. Thus, the second hypothesis was not 
confirmed.  
 
Hypothesis 3: There will be no more than a medium effect size difference 
between the IQ estimates for participants with a dementia compared with 
the healthy control group on the STW-2. 
An independent t-test found a significant difference on the STW-2 between 
people with a dementia (M = 96.8, SD = 7.8) and healthy individuals (M = 102.8, 
SD = 8.8; t (48) = 2.837, p = .010). There was a mean difference between the 
groups of 6.94 (95% CI: 1.45 – 10.44) with an effect size just above medium (r 
= .34). Therefore, the third hypothesis was supported. 
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Hypothesis 4: The discrepancy between a demographic based estimate of 
pre-morbid IQ and estimates derived from tests of reading ability will be 
significantly greater for those with dementias than healthy controls.  
Discrepancy scores were calculated (for each individual) between the 
demographic equation and the two reading tests. The median scores for each 
group and IQ estimator and are seen below in Figure 3.  
There was no significant difference between the control group (Md = 105.83, n 
= 30) and the dementia group (Md = 103.71, n = 30; U = 387.0, z = - .932, p = 
.354, r = .12) on the demographically-estimated IQ. 
 Figure 3: Median discrepancy scores between demographic equation IQ and 
reading test IQ by group 
 
For TOPF vs demographic equation discrepancy scores there was a significant 
difference between controls (Md = 4.93, n = 30) and participants with a 
dementia (Md = 6.82, n = 30; U = 316.0, z = -1.981, p = .048, r = -.26). There 
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was also a significant difference in STW-2 vs demographic equation 
discrepancy scores between controls (Md = 4.98, n = 29) and people with a 
dementia (Md = 8.91, n = 27; U = 266.5, z = -2.05, p = .04, r = .27). The fourth 
hypothesis was confirmed, with a small-to-medium effect size.  
 
An additional analysis was undertaken to compare the reading test vs 
demographic equation discrepancies within groups, using Wilcoxon Signed 
Ranked tests.  
 
In healthy individuals, there was no significant difference between the TOPF vs 
demographic discrepancy score (Md = 4.93, n = 30) and the STW-2 vs. 
demographic discrepancy score (Md = 4.98, n = 29; z = -1.106, p = .269, r = 
.14). 
 
There was also no significant difference between the TOPF vs demographic 
discrepancy score (Md = 6.82, n = 30) and the STW-2 vs. demographic 
discrepancy score (Md = 8.91, n = 27; z = -1.411, p = .158, r = .19) in people 
with a dementia. Therefore, within groups there was no difference between the 
discrepancy scores. 
 
Further analyses 
As severity of disease has been reported to affect the validity of reading tests, a 
further analysis was undertaken to explore this. The manuals for both reading 
tests recommend the use of a combined “reading-test plus demographic 
variables” which is achieved using an accompanying CD ‘Scorer’ – therefore an 
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analysis was undertaken to ascertain whether there was any difference 
between the reading tests and the combined approach. The combined 
approach will henceforth be called “Scorer” (ie ‘TOPFScorer and STW-
2Scorer’). Correlations were undertaken to determine how well the three IQ 
estimators correlated with one another. Finally, the difference discovered 
between healthy controls and people with a dementia was examined to 
determine what, if any, implications there may for clinical practice.  
 
Severity of dementia 
As this study did not use a measure such as the Mini Mental State Examination 
(MMSE; Folstein, Folstein and McHugh, 1975), which has traditionally been 
utilised to categorise severity levels of dementia (e.g. Patterson, Graham & 
Hodges, 1994), the dementia group was arbitrarily split into two based on the 
median score on the ACE-III, which was 65. Thus a “less impaired” group (n = 
15) constituted an ACE-III score of ≥65 and a “more impaired” group (n = 15) 
was comprised of individuals with a score of <65.  
 
Tests were re-run on the TOPF, STW-2 and demographic equation for the 
control and “less impaired” dementia group and the control and “more impaired” 
dementia group. The results are displayed in Figure 4.  
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Figure 4: Mean and median IQ scores for healthy controls, “less impaired” and 
“more impaired” dementia groups, by estimator 
 
The results were no longer significantly different between healthy individuals 
(Md = 101.0, n = 30) and the “less impaired” group (Md = 97.0, n = 15) for the 
TOPF (U = 159.5, z = -1.579, p = .114, r = 0.24). There was also no significant 
difference between healthy controls (Md = 105.8, n = 30) and the “less 
impaired” group (Md = 103.7, n = 15) on the demographic equation (U = 196.5, 
z = - .686, p = .493, r = .10). Finally there was a non-significant result between 
the control (M = 102.8, SD = 8.8) and the “less impaired” dementia group (M = 
97.7, SD = 7.5) for the STW-2 (t (42) = 1.904, p = .064, r = .29, 95% CI -.31 – 
10.5).  
 
There was a significant difference on the TOPF for the control group (Md = 
101.0, n = 30) and the “more impaired” group (Md = 96.0, n = 15; U = 112.0, z = 
-2.726, p = .006, r = 0.41). The difference on the STW-2 between the controls 
(M = 102.8, SD = 8.8) and the “more impaired” group (M = 95.7, SD = 8.5; t (39) 
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= 2.335, p = .025, r = .38, 95% CI: 0.9 – 13.1) was also statistically significant. 
There was no such difference on the demographic equation between the 
controls (Md = 105.8, n = 30) and the “more impaired” group (Md = 103.7, n = 
15; U = 190.5, z = -.831, p = 0.406, r = 0.12).  
 
Despite these differences in statistical significances between the groups, it must 
be noted that the dementia group was split into two, thus each containing only 
fifteen participants per group. The implications of this and consideration of the 
different effect sizes are considered further in the discussion section.  
 
Combined reading test scores and demographic variables 
The accompanying manuals for TOPF and STW-2 recommend using the 
reading test score plus age and years of education to determine premorbid IQ. 
A CD-Rom ‘Scorer’ is provided with the test materials to allow clinicians to enter 
the appropriate data and the ‘Scorer’ then computes the IQ score. These 
‘Scorer’ estimated IQs were calculated for each patient and compared against 
reading test-only estimated IQs. The results are presented below in Figure 5. 
 
There were significant differences between the TOPF (Md = 96.0, n = 30) and 
TOPFScorer (Md = 94.5, n = 30; z = -2.458, p = .014, r = .32) and the STW-2 
(M = 96.8, SD = 7.8) and STW-2-Scorer (M = 94.8, SD = 9.9; t (26) = 2.519, p = 
.018) for people with a dementia. The Scorer provided a slightly lower estimated 
IQ score than the reading tests alone in people with a dementia. 
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Figure 5: Comparison of reading test-estimated IQ scores and Scorer-estimated 
IQ scores, by group 
 
 
A Wilcoxon Signed Rank test revealed a significant difference between the 
TOPF (Md = 101.0, n = 30) and the TOPFScorer (Md = 99.7, n = 30) and a 
paired t-test significant found difference between the STW-2 (M = 102.8, SD = 
8.8) and STW-2Scorer (M = 100.7, SD = 11.8; t (28) = 2.439, p = .018) for 
controls. The Scorer provided a slightly lower estimated IQ score than the 
reading tests alone in healthy individuals.  
 
Association between measures 
For both groups, Spearman’s rho correlations were undertaken between the 
TOPF, STW-2, demographic equation and the scatter plots are presented in 
Figure 6.  
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Figure 6: Scatter plots of the relationships between IQ estimators for each group 
 
In the control group, there were significant positive relationships between the 
TOPF and STW-2 (rho = .766, p < .001), the TOPF and the demographic 
equation (rho = .507, p = .004) and the STW-2 and the demographic equation 
(rho = .674, p < .001).  
 
For the dementia group, there was a significant positive relationship between 
the TOPF and STW-2 (rho = .453, p = .018), the TOPF and the demographic 
equation (rho = .479, p = .007) and the STW-2 and the demographic equation 
(rho = .441, p = .021). The three measures all appeared to correlate significantly 
with one another overall and within groups. 
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Discussion 
This study sought to investigate three measures of estimating premorbid 
intelligence: a reading test (TOPF), a lexical-decision making test (STW-2) and 
a demographic equation. The main aim was to determine how the TOPF 
compared to these other estimators in people with an Alzheimer’s, vascular or 
mixed dementia. As the control and dementia groups were well-matched on age 
and years of education, these variables were unlikely to have impacted on the 
results. 
 
Findings of this study 
Comparison of reading-based tests 
The TOPF and STW-2 provided similar scores for people with a dementia and 
there was no significant difference between the two. Therefore, neither one is 
superior to the other in estimating IQ. It is interesting to note that three 
participants with dementia and one healthy individual were either distressed by 
the STW-2 or refused to complete it. Nearly all participants stated a preference 
for the TOPF, perhaps due to the fact that the test starts with relatively simple 
words to read aloud and then gradually increases in difficulty. In contrast, the 
STW-2 was often perceived as challenging from the first or second page of 
word-pairs. Furthermore, the TOPF can be completed in a much shorter time 
than the STW-2, and there is a discontinuation rule for 5 consecutive scores of 
‘0’; therefore the test was discontinued reasonably soon after the demands of 
the task exceeded the individual’s capabilities. The STW-2, however, has no 
discontinuation rule and thus participants were required to complete all 100 
word-pairs regardless of performance.  
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Reading-based test IQs vs. demographically-based IQs 
The control group and dementia group were comparable with one another in 
terms of their demographic equation-estimated IQ scores but different from one 
another on their reading test-estimated IQ scores. There was a greater 
discrepancy for people with a dementia between the demographic equation IQ 
and the reading tests than for healthy matched controls. The demographic 
equation (used for both the control and dementia group) has to be treated with 
some caution given that it was based on the WAIS-R (see ‘limitations’ section).  
  
Combined reading test scores and demographic variables (Scorer) 
The reading tests on their own appeared to provide a slightly higher IQ score for 
both healthy individuals and people with a dementia. This study found that the 
TOPF and STW-2 estimated IQs for people with a dementia were at least 5 IQ 
points lower compared with matched controls, and the Scorer provided a lower 
score still. This raises the possibility that the reading tests are underestimating 
premorbid IQ in people with dementia, and in the sample for this study the 
Scorer exaggerated this underestimate. 
 
Severity of dementia and performance on reading-based tests 
Participants with a dementia could not be formally classified into severity levels 
as this would have required the use of a tool validated for this purpose. 
Participants were likely to have a mild / moderate level of dementia as all could  
follow instructions and had been deemed able to provide consent to participate 
by the NHS team.  
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There was a wide variation in scores on the ACE-III demonstrating that some 
participants were more cognitively impaired than others. The arbitrary 
classification into “less impaired” and “more impaired” did provide a method of 
categorising severity, albeit one which has not been validated. After this 
classification, there was no longer a significant difference between the “less 
impaired” dementia groups and the control group on the TOPF and STW-2 but 
there remained a significant difference for the “more impaired” group.  
 
The two dementia groups, however, were small in number (both n = 15) and it 
may be more meaningful to consider the effect sizes. Overall, a medium effect 
size was evident between the control group and entire dementia group on the 
TOPF and STW-2. These effect sizes were only reduced slightly in the less 
impaired group, and still suggested a medium size difference. Effect sizes were 
slightly higher for the “more impaired” group. Differences in statistical 
significance are likely to be due to a modest sample size and accompanying 
lack of power.  
 
Clinical implications of inaccurate TOPF scores for people with a dementia 
The actual difference in IQ scores on the TOPF was approximately 5 IQ points 
lower for people with a dementia. It is important for practitioners to understand 
the extent to which this might impact on the clinical interpretation of obtained-
minus-predicted IQ scores. The TOPF ‘Scorer’ provides a method of 
investigating this by comparing the obtained (i.e. WAIS-IV) IQ and the predicted 
(i.e. TOPF) premorbid IQ. If the “true” obtained-minus-predicted discrepancy 
score for an individual was 10 IQ points, the TOPF ‘Scorer’ suggests that this 
degree of discrepancy would only be exhibited by approximately 15% of the UK 
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population which is relatively uncommon. However, if the TOPF-predicted IQ is 
5 points lower than it should be, this would provide an obtained-minus-predicted 
discrepancy score of 5 IQ points, which the TOPF ‘Scorer’ suggests would be 
exhibited by approximately 30% of the UK population and which would be 
relatively common. The confidence intervals for these percentages are quite 
large, suggesting the results should be analysed and reported cautiously, 
however it is often the primary statistic (i.e. 15% or 30%) which is considered in 
practice. 
 
This highlights that such an inaccuracy on the TOPF may have an effect on how 
discrepancy results are interpreted and, in the cases of mild dementia, may 
disconfirm a diagnosis of dementia for the patient when in fact there has been a 
decline in functioning. 
 
Limitations of the study 
The G*Power calculation recommended a minimum of 36 participants per group 
and only 30 were able to be recruited, although this was still enough to detect a 
medium effect size between the groups on the reading tests. Had there been a  
larger number of participants, there may have been enough power to detect a 
significant finding when the dementia group was split into two. 
 
The present study also relied on a comparison between the healthy controls 
and the dementia patients, with the assumption that they would have similar 
IQs. Some research tentatively suggests that people who develop a dementia 
have lower levels of intellectual functioning and this may have been the case for 
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the dementia group in the current study. Whalley, Starr, Athawes, Hunter, Pattie 
and Deary (2000) examined data from the 1932 Scottish birth cohort (where 
children were given IQ tests aged 11) and discovered  that mental ability scores 
were significantly lower in children who eventually developed late-onset 
dementia compared with those who did not. The groups in the current study, 
however, were well matched in terms of age, gender, years of education and 
occupational status, all factors known to affect intelligence, and thus the risk of 
bias in terms of the dementia group having lower IQs was minimised. 
 
This study had to rely on a demographic equation which was developed to 
estimate WAIS-R IQs; this was necessary because there have not been any 
updated regression equations for the WAIS-IV. Both the TOPF and STW-2 have 
been normed against the WAIS-IV; therefore the comparability of the reading-
based tests IQ scores and demographic equation IQ scores is problematic and 
these results should be interpreted cautiously. 
 
Previous versions of the WAIS have been investigated as to the comparability 
of scores. For example, Crawford et al. (1990) explored the comparability of the 
WAIS and WAIS-R in a UK sample and reported mean differences for FSIQ, 
VIQ and PIQ of 7.5, 6.4, and 7.9, respectively, with participants scoring lower on 
the WAIS-R across each domain. The increased difficulty of new IQ tests is to 
account for the Flynn effect (Flynn, 2007) – the finding that individuals will show 
an increase of approximately 3 IQ points per decade.  
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The WAIS-R demographic calculation may have provided an over-inflated IQ 
score and thus the difference between this and the reading-based test IQ may 
have been smaller than reported in this study. However, as the same equation 
was used for both groups, the key issue is the degree of discrepancy for each 
group between the demographic equation and the reading tests; there were no 
differences within groups between these discrepancy scores, however there 
were significant differences between healthy controls and people with a 
dementia on discrepancy scores for both reading tests. 
 
Findings of this study in comparison to other studies 
The results of the current study confirm those of McFarlane et al.’s (2006) 
findings; there was a deterioration in word-reading ability in people with a 
dementia. The current study did find differences between groups on STW-2, 
which is in contrast to McFarlane et al.’s study. This could be accounted for by 
the fact that the current study used a newer (and different) version of the STW-2 
and may have included more impaired participants. 
 
Other researchers have also reported a deterioration in word-reading ability for 
people with a dementia. Lowe and Rogers (2011) investigated the American 
version of the NART and found scores declined as cognitive impairment 
increased. Taylor et al. (1996) also demonstrated that estimates of verbal IQ 
declined over time in a longitudinal study. Paque and Warrington (1995) 
concluded that the NART was a useful estimator of premorbid intelligence in 
early dementia although observed a modest decline in NART-estimated IQs (M 
= 5 IQ points lower). This finding of a reduction in IQ by approximately 5 IQ 
points is consistent with the results of the current study. Fromm, Holland, Nebes 
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and Oakley (1991) conducted a longitudinal study of the NART in controls and 
people with Alzheimer’s disease over a three-year period and found not only 
that controls scored better than the dementia group at each testing but that 
people with a dementia scored significantly worse over time.  The current study 
also noted a difference between healthy controls and people with a dementia. 
 
The above studies are, however, qualitatively different from the current study, in 
that they are longitudinal and the current study assessed people at one time 
point. The longitudinal studies recruited patients with a mild dementia and 
tracked them over time, which suggests severity of dementia was increasing. 
The present study recruited patients with a likely mild/moderate dementia who 
may or may not be comparable with the participants in the above studies after 
they had been retested. The fact that the current study did not formally assess 
the severity levels of participants with a dementia makes it hard to compare 
against these other studies. 
 
Future research 
One obvious possibility for future research is to replicate this study with a larger 
number of participants, particularly within the “dementia” group so that when the 
group is split into severity levels the study has a greater degree of power to 
detect differences between measures and groups.  
 
Utilising a recognised tool for assessing severity of dementia, such as the 
MMSE, would also provide a validated method of identifying the score at which 
the TOPF becomes compromised in people with a dementia. This would 
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provide clinicians with a more concrete answer as to when the TOPF can be 
used with relative confidence (e.g. a score of ≥ 20 on the MMSE).  
 
Furthermore, a larger scale study with a longer period of recruitment could also 
administer a measure of current (obtained) IQ score (e.g. a current WAIS). This 
would then allow predicted and obtained scores to be calculated between 
matched healthy controls and people with a dementia.  
 
There are currently no updated demographic regression equations for the 
WAIS-IV and if such an equation were developed, it could be compared with the 
TOPF, STW-2 and an obtained WAIS-IV IQ. This would then give an indication 
as to which method may be the most accurate in estimating premorbid 
intelligence. 
 
Much of the current research on the validity of reading tests in estimating 
premorbid intelligence involves older tests such as the NART which are no 
longer used in clinical practice. Furthermore, many of these studies were poorly 
reported (e.g. did not provide details of years of education or occupational 
status) and failed to match controls with patients. Therefore, more stringent 
research is required in this field addressing some of these issues. 
 
Conclusion 
This study has found differences between people with a dementia and matched 
healthy controls on the TOPF and STW-2, albeit a relatively small difference. 
Other studies have reported some similar results, although they are not directly 
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comparable with the current study and often suffered from poor reporting 
standards.  
 
In conducting a neuropsychological assessment of an individual to determine 
whether there is evidence of a dementia, a range of tests may be used to 
assess a variety of cognitive domains. Typically these domains might include 
episodic memory, language and semantic knowledge, abstract reasoning, 
visuospatial abilities, attention and executive functioning (Salmon & Bondi, 
2009). It is common practice, where practical, to also try to establish whether 
there has more a more general decline in intellectual functioning, by assessing 
current IQ and comparing this against an estimate of premorbid IQ (such as a 
reading test-estimated IQ). If reading tests systematically underestimate 
premorbid IQ in people who do have a dementia then clinicians may 
inadvertently conclude that the person is showing relatively little decline in IQ 
and there is no evidence suggestive of a dementia. The confidence intervals 
around the relative frequency of obtained-minus-predicted IQ discrepancies 
should alert clinicians to exercise caution when interpreting reading test scores.  
 
The results of this study further highlight that such caution is necessary when 
considering the results of reading tests such as the TOPF and STW-2 and with 
clear reference to the clinical history and other cognitive test results. 
 
 Although this is small-scale study and conclusions must be drawn tentatively, 
the results suggest the TOPF is not a particularly robust measure of premorbid 
intelligence in people with a dementia.
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Chapter 3: Advanced Clinical Practice I- Reflective Critical Account 
 
A changing relationship with Cognitive Behavioural Therapy 
 
Abstract 
 
In this reflective account I apply Gibb’s (1988) reflective model combined with 
elements of John’s (1994) model of structured reflection to my first two years of 
Doctorate training. Using these models, I identify my initial preconceptions 
about the applicability and utility of Cognitive Behavioural Therapy and consider 
my changing perspective across this time period as I gained experience in using 
the model with different patient groups.  
From this process I consider how I have assimilated these polarised positions 
and learning experiences into a more balanced perspective and how the 
process of reflection will guide me as I prepare to once again work within the 
limits of an adult Community Mental Health team. 
Finally I consider how financial and service constraints impact on the stepped 
care model and Clinical Psychology, and how I can find my place within this. 
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Chapter 4: Advanced Clinical Practice II- Reflective Critical Account 
 
From the “Ivory Tower” to the board room: Clinical Psychology as part of 
the Multi-Disciplinary Team 
 
Abstract 
Team-working is a core component of the work of Clinical Psychologists. In this 
reflective account I apply Gibb’s (1988) reflective model combined with John’s 
(1994) model of structured reflection to consider my experiences of working in 
Multi-Disciplinary Teams (MDTs) across the three years of my training.   
From this process I consider how professional status and boundaries, 
organisational cultures and pressures, and historical contexts have affected the 
development of the teams I have been a part of. I also explore my personal 
reactions and contributions to these systems and how my own insecurities have 
affected my ability to interact with both well-integrated and less well integrated 
teams. 
Finally I consider what learning points I need to take forward in the future as I 
move towards becoming a qualified practitioner seeking to make my own 
contribution to the field of Psychology and Multi-Disciplinary working. 
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Appendix 1.1: Publication ‘Instructions for Authors’ 
Psychological Assessment ® is concerned mainly with empirical research relevant to assessments 
conducted in the broad field of clinical psychology. Integrative reviews of research in this area are also 
welcome. 
Relevant topics include 
 clinical judgment and the application of decision-making models 
 paradigms derived from basic psychological research in cognition, personality–social psychology, 
and biological psychology 
 development, validation, and application of assessment instruments, scales, observational 
methods, and interviews 
 research on clinical judgment and decision-making 
 studies supporting or leading to translation of basic psychological research in cognition, 
personality–social psychology, and biological psychology to clinical psychological assessment 
The focus of the journal is on all aspects of clinical assessment. 
Clinically-focused assessment of personality, psychopathological symptoms, cognitive and 
neuropsychological processes, and interpersonal behavior are all relevant. Methodological, theoretical, 
and review articles addressing clinical assessment processes and methods are also welcome. 
Investigations supporting clinical assessment in mental health, medical, forensic, and personnel screening 
settings are welcome. Research on under-studied populations is particularly encouraged. Case studies will 
be considered if they make unique contributions to clinical psychological assessment. Papers that focus on 
measurement theory and methods will be considered if specifically focused on issues in clinical 
assessment. 
Submission 
Manuscripts concerned with the development of a new assessment instrument should include a copy of 
the instrument. 
In general, manuscripts should be no longer than 40 pages (this includes all elements of the manuscript, 
with the exception of any supplemental material). 
Submit manuscripts electronically through the Manuscript Submission Portal. 
General correspondence may be directed to the Editor's Office. 
Masked Review 
This journal has adopted a masked review policy for all submissions. Authors should make every effort to 
ensure that the manuscript itself contains no clues to their identities. Authors' names and affiliations should 
not appear in the manuscript. Instead, please include this information in just the cover letter. 
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Please ensure that the final version for production includes a byline and full author note for typesetting. 
Brief Reports 
Psychological Assessment will review brief reports of research studies in clinical assessment. The 
procedure is intended to permit the publication of carefully designed studies with a narrow focus or of 
specialized interest. 
An author who submits a brief report must agree not to submit the full report to another journal of general 
circulation. The brief report should give a clear, condensed summary of the procedure of the study and as 
full an account of the results as space permits. 
The brief report should be limited to 19 manuscript pages (1" margins, size 12 font). This includes the title 
page, abstract, author note, text, reference list, and any footnotes, tables, and figures. The number of 
tables and figures should be limited. 
The author is encouraged to limit the number of headings within the brief report and to combine headings 
whenever possible. For example, the Results and Discussion sections can be combined. Also, 
subheadings under the Method section can often be omitted. 
Authors are encouraged but not required to have available an extended report. If one is available, the 
author note of the brief report should include the following statement: 
Correspondence concerning this article (and requests for an extended report of this study) should 
be addressed to [give the author's full name and address]. 
Research on Translations of Tests 
Psychological Assessment rarely publishes in print psychometric studies of translations of tests unless the 
papers also address some conceptual or methodological issue of broader interest to clinical assessment. 
However, we have a special online only publishing option for such Research on Translations of Tests 
articles. With this option, manuscripts undergo our normal review process and are held to the same 
standards of review as all other submissions to the journal, but, if accepted, they would not appear in the 
print version of the journal but rather online only. 
Studies appropriate for this option must have a focus consistent with the editorial scope of the journal, 
which emphasizes clinical assessment research. 
These articles would be listed in all Tables of Contents (online and print), would be clearly identified as 
published "Online Only," and the DOI identifier would be included in the Table of Contents. Also, full text 
copies of the translated tests would go into PsycTESTS. 
Translations of commercially published tests are not eligible for review in this category because, in addition 
to copyright constraints, such translations are not consistent with the goals of our Research on 
Translations of Tests program or PsycTESTS. Translations of single scales are also not eligible. 
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Authors wishing to submit manuscripts in this category should select the "Research on Translations of 
Tests" article type when submitting their manuscript. 
Manuscript Preparation 
Prepare manuscripts according to the Publication Manual of the American Psychological Association (6th 
edition). Manuscripts may be copyedited for bias-free language (see Chapter 3 of the Publication Manual). 
Review APA's Checklist for Manuscript Submission before submitting your article. 
Double-space all copy. Other formatting instructions, as well as instructions on preparing tables, figures, 
references, metrics, and abstracts, appear in the Manual. 
Below are additional instructions regarding the preparation of display equations, computer code, and 
tables. 
Display Equations 
We strongly encourage you to use MathType (third-party software) or Equation Editor 3.0 (built into pre-
2007 versions of Word) to construct your equations, rather than the equation support that is built into Word 
2007 and Word 2010. Equations composed with the built-in Word 2007/Word 2010 equation support are 
converted to low-resolution graphics when they enter the production process and must be rekeyed by the 
typesetter, which may introduce errors. 
To construct your equations with MathType or Equation Editor 3.0: 
 Go to the Text section of the Insert tab and select Object. 
 Select MathType or Equation Editor 3.0 in the drop-down menu. 
If you have an equation that has already been produced using Microsoft Word 2007 or 2010 and you have 
access to the full version of MathType 6.5 or later, you can convert this equation to MathType by clicking 
on MathType Insert Equation. Copy the equation from Microsoft Word and paste it into the MathType box. 
Verify that your equation is correct, click File, and then click Update. Your equation has now been inserted 
into your Word file as a MathType Equation. 
Use Equation Editor 3.0 or MathType only for equations or for formulas that cannot be produced as Word 
text using the Times or Symbol font. 
Computer Code 
Because altering computer code in any way (e.g., indents, line spacing, line breaks, page breaks) during 
the typesetting process could alter its meaning, we treat computer code differently from the rest of your 
article in our production process. To that end, we request separate files for computer code. 
In Online Supplemental Material  
We request that runnable source code be included as supplemental material to the article. For more 
information, visit Supplementing Your Article With Online Material. 
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In the Text of the Article  
If you would like to include code in the text of your published manuscript, please submit a separate file with 
your code exactly as you want it to appear, using Courier New font with a type size of 8 points. We will 
make an image of each segment of code in your article that exceeds 40 characters in length. (Shorter 
snippets of code that appear in text will be typeset in Courier New and run in with the rest of the text.) If an 
appendix contains a mix of code and explanatory text, please submit a file that contains the entire 
appendix, with the code keyed in 8-point Courier New. 
Tables 
Use Word's Insert Table function when you create tables. Using spaces or tabs in your table will create 
problems when the table is typeset and may result in errors. 
Submitting Supplemental Materials 
APA can place supplemental materials online, available via the published article in the PsycARTICLES® 
database. Please see Supplementing Your Article With Online Material for more details. 
Abstract and Keywords 
All manuscripts must include an abstract containing a maximum of 250 words typed on a separate page. 
After the abstract, please supply up to five keywords or brief phrases. 
References 
List references in alphabetical order. Each listed reference should be cited in text, and each text citation 
should be listed in the References section. 
Examples of basic reference formats: 
 Journal Article:  
Hughes, G., Desantis, A., & Waszak, F. (2013). Mechanisms of intentional binding and sensory 
attenuation: The role of temporal prediction, temporal control, identity prediction, and motor 
prediction. Psychological Bulletin, 139, 133–151. http://dx.doi.org/10.1037/a0028566 
 Authored Book:  
Rogers, T. T., & McClelland, J. L. (2004). Semantic cognition: A parallel distributed processing 
approach. Cambridge, MA: MIT Press. 
 Chapter in an Edited Book:  
Gill, M. J., & Sypher, B. D. (2009). Workplace incivility and organizational trust. In P. Lutgen-
Sandvik & B. D. Sypher (Eds.), Destructive organizational communication: Processes, 
consequences, and constructive ways of organizing (pp. 53–73). New York, NY: Taylor & Francis. 
Figures 
Graphics files are welcome if supplied as Tiff or EPS files. Multipanel figures (i.e., figures with parts labeled 
a, b, c, d, etc.) should be assembled into one file. 
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The minimum line weight for line art is 0.5 point for optimal printing. 
For more information about acceptable resolutions, fonts, sizing, and other figure issues, please see the 
general guidelines. 
When possible, please place symbol legends below the figure instead of to the side. 
APA offers authors the option to publish their figures online in color without the costs associated with print 
publication of color figures. 
The same caption will appear on both the online (color) and print (black and white) versions. To ensure 
that the figure can be understood in both formats, authors should add alternative wording (e.g., "the red 
(dark gray) bars represent") as needed. 
For authors who prefer their figures to be published in color both in print and online, original color figures 
can be printed in color at the editor's and publisher's discretion provided the author agrees to pay: 
 $900 for one figure 
 An additional $600 for the second figure 
 An additional $450 for each subsequent figure 
Permissions 
Authors of accepted papers must obtain and provide to the editor on final acceptance all necessary 
permissions to reproduce in print and electronic form any copyrighted work, including test materials (or 
portions thereof), photographs, and other graphic images (including those used as stimuli in experiments). 
On advice of counsel, APA may decline to publish any image whose copyright status is unknown. 
 Download Permissions Alert Form (PDF, 13KB) 
Publication Policies 
APA policy prohibits an author from submitting the same manuscript for concurrent consideration by two or 
more publications. 
See also APA Journals® Internet Posting Guidelines. 
APA requires authors to reveal any possible conflict of interest in the conduct and reporting of research 
(e.g., financial interests in a test or procedure, funding by pharmaceutical companies for drug research). 
 Download Disclosure of Interests Form (PDF, 38KB) 
Authors of accepted manuscripts are required to transfer the copyright to APA. 
 For manuscripts not funded by the Wellcome Trust or the Research Councils UK  
Publication Rights (Copyright Transfer) Form (PDF, 83KB) 
 95 
 For manuscripts funded by the Wellcome Trust or the Research Councils UK  
Wellcome Trust or Research Councils UK Publication Rights Form (PDF, 34KB) 
Ethical Principles 
It is a violation of APA Ethical Principles to publish "as original data, data that have been previously 
published" (Standard 8.13). 
In addition, APA Ethical Principles specify that "after research results are published, psychologists do not 
withhold the data on which their conclusions are based from other competent professionals who seek to 
verify the substantive claims through reanalysis and who intend to use such data only for that purpose, 
provided that the confidentiality of the participants can be protected and unless legal rights concerning 
proprietary data preclude their release" (Standard 8.14). 
APA expects authors to adhere to these standards. Specifically, APA expects authors to have their data 
available throughout the editorial review process and for at least 5 years after the date of publication. 
Authors are required to state in writing that they have complied with APA ethical standards in the treatment 
of their sample, human or animal, or to describe the details of treatment. 
 Download Certification of Compliance With APA Ethical Principles Form (PDF, 26KB) 
The APA Ethics Office provides the full Ethical Principles of Psychologists and Code of Conduct 
electronically on its website in HTML, PDF, and Word format. You may also request a copy by emailing or 
calling the APA Ethics Office (202-336-5930). You may also read "Ethical Principles," December 1992, 
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Appendix 1.2: Detailed search strategy 
 
1. AB dement* OR AB alzheimer* OR AB multi?infarct dement* OR AB 
cognitive deterioration OR AB cognitive decline OR AB intell* 
deterioration OR AB mental deterioration OR MM dementia OR MW 
Alzheimers OR MW dementia, vascular   
 
2. AB pre?morbid IQ OR AB pre?morbidintell* OR AB pre?morbidestimat* 
OR AB pre?morbidabilit* OR AB intell* OR AB estimat* pre?morbid OR 
AB estimat* intell* OR MW Psychometrics OR MW Intelligence OR MW 
Intelligence tests  
 
3. AB read* OR AB reading test* OR AB reading abilit* OR AB irregular 
word* OR MW reading  
 
4. AB VIQ OR AB verbal IQ OR AB verbal intell* OR AB demographic 
equation* OR AB demographic regression equation* OR AB 
demographic variable* OR MW psychometrics OR MW intelligence tests 
OR MW intelligence OR MW neuropsychological tests  
 
5. Combine 1 AND 2 AND 3 AND 4 
 
6. Limit 5 to “English” and “All adult” 
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Appendix 1.3: Quality Rating Checklist 
STROBE 2007 (v4) checklist of items to be included in reports of observational studies in epidemiology 
Checklist for cohort, case-control, and cross-sectional studies (combined) 
 
Section / 
Topic 
Item 
# 
Recommendation Reported 
on page # 
Title and 
abstract 
1 (a) Indicate the study’s design with a commonly used term in the title or the abstract  
  (b) Provide in the abstract an informative and balanced summary of what was done and what was found  
INTRODUCTION 
Background / 
rationale 
2 Explain the scientific background and rationale for the investigation being reported  
Objectives 3 State specific objectives, including any pre-specified hypotheses  
METHODS 
Study design 4 Present key elements of study design early in the paper  
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, 
and data collection 
 
Participants 6 (a) Cohort study - Give the eligibility criteria, and the sources and methods of selection of participants. 
Describe methods of follow-up. For matched studies, give matching criteria and number of exposed and 
unexposed 
 
Case-control study – Give the eligibility criteria, and the sources and methods of case ascertainment and 
control selection. Give the rationale for the choice of cases and controls. For matched studies, give 
matching criteria and the number of controls per case 
 
Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of 
participants 
 
 
 
 
 
 
/1 
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Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders and effect modifiers  
Data sources / 
measurement 
8* For each variable of interest, give sources of data and details of methods of assessment (measurement). 
Describe comparability of assessment methods if there is more than one group 
 
Bias 9 Describe any efforts to address potential sources of bias  
Study size 10 Explain how the study size was arrived at  
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings 
were chosen and why 
 
Statistical 12 (a) Describe all statistical methods, including those used to control for confounding variables  
  (b) Describe any methods used to examine subgroups and interactions  
  (c) Explain how missing data were addressed  
  (d) Cohort study – If applicable, explain how loss to follow-up was addressed 
Case-control study – Explain how matching of cases and controls was addressed 
Cross-sectional study – If applicable, describe analytical methods taking account of sampling strategy 
 
 
 
 
/1 
  (e) Describe any sensitivity analyses  
RESULTS 
Participants 13* (a) Report numbers of individuals at each stage of study – e.g. numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, completed follow-up, and analysed 
 
  (b) Give reasons for non-participation at each stage  
  (c) Consider use of a flow diagram  
Descriptive 
data 
14* (a) Give characteristics of study participants (e.g. demographic, clinical, social) and information on 
exposures and potential confounders. Cohort study - Summarise the follow-up time (e.g. average and 
total amount) 
 
 
  (b) Indicate number of participants with missing data for each variable of interest /1 
Outcome data 15* Cohort study - Report numbers of outcome events or summary measures over time 
Case-control study – Report numbers in each exposure category, or summary of measures of exposure 
Cross-sectional study – Report numbers of outcome events or summary measures 
 
 
/1 
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Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 
95% confidence interval). Make clear which confounders were adjusted for and why they were included 
AND 
(b) Report category boundaries when continuous variables were categorized 
 
 
 
/1 
Other analyses 17 Report other analyses done—e.g. analyses of subgroups and interactions, and sensitivity analyses  
DISCUSSION 
Key results 18 Summarise key results with reference to study objectives  
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both 
direction and magnitude of any potential bias 
 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, 
results from similar studies, and other relevant evidence 
 
Generalisability 21 Discuss the generalisability (external validity) of the study results  
OTHER INFORMATION 
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the 
original study on which the present article is based 
 
      Total score:     /30 
 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The 
STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal 
Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe‐statement.org. 
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Additional Checklist 
Section / topic Item # Recommendation Reported 
on page # 
Study design 1 The study recruits participants with an actual IQ obtained (i.e. prior to the onset of a dementia and, for 
healthy controls, prior to the study being commenced) 
 
Participants 2 (a) Clearly specifies which diagnostic criteria was applied for participants with a dementia  
AND  
Where a control group is recruited, screening for cognitive impairment is detailed using a validated 
instrument e.g. MMSE, ACE-III 
 
 
/1 
(b) Criteria used is a “gold standard” e.g. NINDS – AIREN, ICD-10, neuro-imaging  
(c) Dementia subtypes are identified e.g. Alzheimer’s, vascular  
(d) Severity levels are differentiated and categorised  
(e) Severity levels are differentiated using a validated instrument e.g. MMSE  
 3 (a) Exclusion criteria are specified  
(b) Exclusion criteria include:  
(i) history of stroke (which has resulted in aphasia) 
(ii)  language disorders and aphasias 
(iii) English not as first language  
(iv) current psychiatric disorder 
(v) head trauma  
(vi) drug/alcohol abuse  
(vii) other neurological disorders 
 
 
 
 
 
 
/7 
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Total score:    /22  
  
Strobe checklist:  /30   Additional Checklist:  /22  Total:  /52 
 4 The sample size is large enough to detect a moderate effect size  
Statistical 
methods 
5 Data has been checked for normal distribution and appropriate parametric or non-parametric tests have 
been utilised 
 
Bias 6 Variables specifically considered and statistically explored for sources of bias are: 
(a)age 
(b)gender 
(c)years of education  
(d)occupational status  
(e)social class 
 
OR 
For matched studies, there a specific reference to matching of: 
(a)age 
(b) gender 
(c)years of education  
(d) occupational status  
(e) social class 
 
 
 
 
 
/5 
Results 7 Effect sizes are reported  
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Appendix 1.5: Demographics of included studies 
Studies are listed and numbered in order of methodological quality. Full references can be found in Appendix 1.4, with associated        
numbers. Study numbers in the results section correspond to numbers listed in this table. 
Study # Rating Readin
g test(s) 
Comparator 
(VIQ or 
Demographic 
equation) 
Inclusion / 
exclusion 
criteria? 
Sample 
size 
No. of 
males 
Diagnostic 
criteria 
(Diagnosis) 
Severity 
level 
assessed? 
Mean 
age (SD) 
Mean 
years 
of Ed. 
(SD) 
1. McFarlane, 
Welch and 
Rodgers 
(2006) 
39/52 NART 
WTAR 
CCRT 
STW 
Demographic  
equation 
(Crawford and 
Allan, 1997) 
Exc: depression, 
stroke, head 
injury, alcohol 
abuse 
Controls    
= 32  (M) 
13 MMSE 
<28 
MMSE 
<28 
70  
(10.8) 
12.1 
(2.9) 
Minimal  = 
30 
14 NINCDS / 
ADRDA 
(AD) 
MMSE      
24-28 
73.6 
(10.6) 
12.2 
(2.9) 
Mild = 36 19 MMSE     
14-23 
75.6 
(10.7) 
10.6 
(2.4) 
2. McGurn et 
al (2004) 
34/52 NART MHT Inc:  people from 
SMS1932 
Controls = 
464 
U/K MMSE < 24 N/A 79.1  
(0.6) 
U/K 
Dementia  
= 45 
 
U/K ICD-10   (AD, 
VD, 
Unspecified 
& Possible 
AD) 
Mostly 
mild to 
moderate 
on 
MMSE 
79.0  
(1.5) 
U/K 
3. Paolo, 
Troster, Ryan 
and Koller 
(1997) 
33/52 NART WAIS-R VIQ 
Demographic 
equation 
(Barona et al, 
Exc: stroke, 
psychiatric 
disorder, head 
trauma, drug / 
alcohol abuse, 
Controls = 
44  (M) 
(M) DRS > 130 DRS > 
130 
U/K (M) U/K      
(M) 
Mild  = 24 22 in 
total 
NINCDS / 
ADRDA 
DRS 110-
130 
74.0 
 (5.7) 
12.7 
(2.7) 
 108 
1984) 
 
other neuro Mod  = 20 (AD) DRS < 
110 
74.2  
(7.0) 
13.2 
(3.4) 
4. O’Carroll et 
al (1995) 
27/52 NART Demographic 
equation 
(Crawford et al, 
1989) 
U/K Min = 9 4 NINCDS / 
ADRDA 
(AD) 
MMSE     
24-30 
65.0 
 (U/K) 
9.8 
(U/K) 
Mild = 46 13 MMSE     
14-23 
74.6 
 (U/K) 
10.6 
(U/K) 
Mod = 13 3 MMSE 
2-13 
71.2  
(U/K) 
10.5 
(U/K) 
5. Hart, Smith 
and Swash 
(1986) 
25/52 SGWR
T 
NART 
WAIS VIQ 
WAIS Vocab 
Clinical & lab 
tests to exclude 
other neuro, 
psychiatric, 
metabolic or 
systemic 
conditions 
Controls = 
15 
6 
 
 
 
U/K 
 
 
 
U/K 
 
 
 
69.5  
(6.4) 
 
 
9.3 
(1.0) 
 
 
AD = 20 12 CT scan 
Ischaemic 
score 
(AD) 
Blessed et 
al (1968) 
37-item 
test 
66.3  
(6.3) 
9.6 
(1.1) 
6. Stebbins et 
al (1990b) 
24/52 NART Demographic 
equation 
(Wilson et al, 
1978) 
U/K Controls = 
26 (M) 
U/K MMSE 
normal range 
MMSE 
normal 
range 
63.5 
 (U/K) 
13.3 
(U/K) 
Very mild 
= 41 
U/K NINCDS / 
ADRDA 
 
(AD, VD, 
MMSE 
24-27 
69.8 
 (U/K) 
12.8 
(U/K) 
Mild = 81 U/K MMSE 
16-23 
72.9  
(U/K) 
12.6 
(U/K) 
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Mod/ Sev 
= 77 
U/K mixed AD/VD) MMSE 
5-15 
72.2  
(U/K) 
12.4 
(U/K) 
7. Maddrey et 
al (1996) 
24/52 NART-
R 
WAIS-R VIQ U/K Mild  = 19 9 NINCDS / 
ADRDA 
(AD) 
 
DRS > 
115 
74.3  
(8.4) 
13.7 
(3.2) 
Mod  = 19 7 DRS 100-
115 
71.6  
(9.0) 
13.8 
(3.5) 
Sev  = 16 7 DRS < 
100 
74.4 
(10.0) 
13.9 
(4.2) 
8. Crawford, 
Parker and 
Besson (1988) 
23/52 NART WAIS Vocab Glen & Christie’s 
(1979) exclusion 
criteria 
Controls 
excluded if neuro 
conditions, head 
injury or alcohol 
abuse 
Controls = 
14 & 8 (M) 
(M) Screened-
interview 
None (M) (M) 
AD = 14 
Severe 
impairment 
U/K NMR 
imaging, 
blood flow 
imaging 
(AD & VD) 
Age-
graded 
scaled 
scores 
68.7 
 (U/K) 
10.3 
(U/K) 
VD = 8 
Severe 
impairment 
U/K Age-
graded 
scaled 
scores 
66.4  
(U/K) 
9.3 
(U/K) 
9. Bright, 
Jaldow & 
Kopelman 
(2002) 
22/52 NART 
NART-
R 
Demographic 
equations 
(Crawford et al, 
1989; Crawford 
& Allan, 1997) 
Excluded if 
perceptual 
difficulties or 
aphasia 
Controls = 
51 total (2 
studies): 
8 (M)  
16 (M) 
 
 
 
2 (M) 
7 (M) 
U/K None Total = 
55.4 
(16.0) 
66.3 (M) 
61.8(M) 
Total 
= 11.2  
(2.6) 
U/K 
U/K 
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AD = 32 
total (from 
2 studies): 
16 AD 
16 AD 
 
 
 
4 
5 
CT scan, 
history, 
psycho- 
metrics 
(AD) 
None  
 
 
65.6 
68.7 
 
 
 
U/K 
U/K 
10. McCarthy, 
Burns & 
Sellers (2005) 
22/52 WRAT-
R 
WRAT-
3 
NART-
R 
Demographic 
equation 
(Barona et al, 
1984) 
Exc: psychiatric 
disorder, drug / 
alcohol abuse, 
stroke, comorbid 
conditions eg VD 
Controls = 
60 
U/K Screened-
interview 
None 75.5 
(6.0) 
13.2 
(2.4) 
Mild = 30 Total 
males 
= 54 
NINCDS / 
ADRDA & 
DSM-III-R 
(AD) 
MMSE    
20-25 
76.4 
(5.1) 
12.8  
(2.9) 
Mod = 30 MMSE    
14-19 
76.5 
(4.9) 
12.8 
 (2.8) 
11. Stebbins et 
al (1990a) 
19/52 NART Demographic 
equation 
(Wilson et al, 
1978) 
Exc: mod/sev 
dementia 
evidenced by 
MMSE < 16 
No 
Language 
disturbance 
= 25 
U/K NINCDS / 
ADRDA 
(AD, VD and 
mixed AD/VD) 
MMSE    
16-23 
U/K U/K 
Naming or 
Fluency 
disturbance 
= 29 
U/K MMSE    
16-23 
U/K U/K 
Naming 
and fluency 
disturbance 
= 14 
U/K MMSE    
16-23 
U/K U/K 
12. O’Carroll, 
Baikie & 
18/52 NART MHVS U/K Dementia = 
30 
8 DSM-III None [Pearsons 
r  matrix 
[Pears
ons r  
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Whittick 
(1987) 
(Diagnoses 
unspecified 
on all 
variables] 
matrix 
on all 
variabl
es] 
13. Paque & 
Warrington 
(1995) 
17/52 NART WAIS-R VIQ Inc: must have 
been tested x 2 on 
NART and x 1 on 
WAIS 
AD = 57 40 U/K 
(AD) 
None 60.5 
(9.5) 
U/K 
14. Johnstone 
et al (1996) 
13/52 WRAT-
R 
NAART 
WAIS-R VIQ Exc: aphasic, 
learning 
disability or 
could not 
complete tests 
AD = 37 28 NINCDS / 
ADRDA 
(AD) 
U/K 64.35 
(12.9) 
12.5 
(3.5) 
15. O’Carroll 
& Gilleard 
(1986) 
13/52 NART MHVS U/K Dementia = 
30 
8 DSM-III 
(Diagnoses 
unspecified 
None [Pearsons 
r  matrix 
on all 
variables] 
[Pears
ons r  
matrix 
on all 
variabl
es] 
16. Taylor 
(1999) 
12/52 NART Demographic 
equation 
(Crawford et al 
1990) 
Exc: Dyslexia, 
aphasia, unable to 
accurately record 
demo variables, 
uncorrected 
sight/hearing 
issues, disability, 
infections, head 
injury, alcohol 
abuse, psychiatric 
Dementia = 
84 
(43 AD, 41 
VD) 
41 NINCDS, 
Ischaemic 
score 
(AD & VD) 
 
None 72.6 
(10.7) 
U/K 
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17. Ruddle & 
Bradshaw 
(1982) 
11/52 SGWR
T 
WAIS VIQ U/K Controls = 
78 
46 U/K U/K 39.2 
(19.3) 
U/K 
Dementia = 
22 
U/K U/K None 64.3 
(14.6) 
U/K 
18. Nelson & 
McKenna 
(1975) 
8/52 
 
  
SGWR
T 
WAIS VIQ 
WAIS Vocab 
U/K Controls = 
98 
U/K U/K U/K 47.2 
(14.5) 
U/K 
Dementia = 
45 
U/K U/K 
(Diagnoses   
unspecified 
U/K 49.0 
(14.5) 
U/K 
 
Table Key 
AD = Alzheimer’s disease;  VD = Vascular dementia         
U/K – Unknown;  (M) = Matched           
NART (-R) = National Adult Reading Test(-Revised) 
NAART = North American Adult Reading Test 
WRAT(-R;-3) = Wide Range Achievement Test(-Revised; 3) Reading subtest 
WAIS(-R) = Wechsler Adult Intelligence Scale(-Revised)        
WAIS Vocab = WAIS Vocabulary subtest   
SGWRT = Schonell Graded Word Reading Test 
WTAR – Wechsler Test of Adult Reading   
NINCDS / ADRDA = National Institute of Neurological and Communicative 
Disorders and Stroke / Alzheimer’s Disease and Related Disorders 
Association                                 
STW = Spot The Word               
CCRT = Cambridge Contextual Reading Test 
MHVS = Mill Hill Vocabulary Scale  
MHT = Moray House Test (No. 12) 
WAIS VIQ = WAIS Verbal IQ 
MMSE = Mini Mental State Examination 
DRS = Dementia Rating Scale 
ICD-10 = International Classification of Diseases (Tenth Edition) 
DSM III (-R) = Diagnostic and Statistical Manual III(-Revised) 
Exc: = Excluded; Inc: = Included 
Min = Minimal; Mod = Moderate; Sev = Severe 
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Abstract 
 
Estimation of premorbid intelligence is a crucial component of 
neuropsychological assessment, providing an accurate baseline from which to 
identify cognitive decline. Three approaches may be utilised by clinicians: 
demographic-based regression equations, lexical decision-making tasks and 
reading exercises. Previous research suggested the National Adult Reading 
Test (NART, a reading ability test, may not be as accurate in predicting 
premorbid intelligence as other approaches. The NART has since been 
replaced with the Test of Premorbid Functioning (TOPF). 
 
This is a cross-sectional design study and the primary objective is to assess the 
robustness of the TOPF, and compare this with the Spot-the-Word version 2 
(STW-2: a lexical decision-making task, and a demographic regression equation 
in estimating premorbid intelligence in people with Alzheimer’s disease (AD), 
vascular disease (VD) and a mixed Alzheimer’s/vascular disease (AVD). The 
scores of thirty-six probable AD, VD and AVD participants (scoring ≤75 on the 
ACE-III) on the TOPF, STW-2 and a demographic equation will be compared 
with 36 healthy age-matched controls using independent t-tests. 
 
If the TOPF does not provide an accurate estimate of premorbid functioning 
then this may have implications for clinical use. 
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 Introduction  
The early detection of a neurodegenerative disease, such as Alzheimer’s, is 
becoming increasingly important as advances are made in pharmacological and 
psychological treatments and research suggests that early intervention may be 
beneficial (The National Audit Office, 2007). Alzheimer’s disease is the most 
common type of dementia, with the National Audit Office estimating that 62% of 
diagnosed dementias are of the Alzheimer’s type, with vascular dementias 
accounting for around 30%.  
NICE (2006) states an assessment of a suspected dementia should be 
comprehensive and include history taking, a medication review and cognitive, 
physical and mental examination. Furthermore NICE states that “formal 
neuropsychological testing should form part of the assessment in cases of mild 
or questionable dementia” (p.21).  
Estimation of premorbid intelligence is now an established and crucial 
component of neuropsychological assessment, due to the need for an accurate, 
albeit estimated, baseline from which to identify any cognitive decline. Currently, 
three approaches may be utilised by clinicians: demographic-based regression 
equations, lexical decision-making tasks and reading ability.  
Reading tasks have become popular in clinical practice and utilise vocabulary 
level as a correlate to IQ. Such tests rely on the resistance of reading ability to 
cognitive impairment associated with early stages of most neurodegenerative 
conditions. 
The participant is presented with irregularly spelled words and prompted to 
pronounce each. The irregular grapheme-to-phoneme translations (such as the 
 120 
“gh” in the word rough) in the words make it difficult to pronounce without 
previous familiarity. Since participants cannot apply standard pronunciation 
rules to complete the task, their vocabulary can be assessed by their ability to 
pronounce the irregularly spelled words, and by extension, estimate their 
premorbid IQ. However, reading tests are not impervious to the effects of 
degenerative disease and several studies (e.g. Cockburn, Keene, Hope and 
Smith, 2000) have demonstrated that reading ability becomes compromised 
with increasing dementia severity. 
Lexical decision tasks measure the ability to classify stimuli (a string of letters) 
as words or non-words.The “Spot The Word” test is one such task which 
research (e.g.Yuspeh and Vanderploeg, 2000) suggests is resistant to cognitive 
impairment and thus provides a useful alternative to reading tests for estimating 
premorbid intellectual functioning. There is now a second version of this test 
(STW-2) in which participants are presented with pairs of words, one of which is 
real and the other a nonsense word. Participants select the real word from the 
pair and there is no requirement for the word to be pronounced. This task allows 
decisions to be made through multiple methods including; meaning, familiarity, 
appearance and sound of words and participants are not penalised for incorrect 
pronunciation. However, this test also appears to significantly decrease in 
accuracy with moderate to severe dementias (e.g. Law & O’Carroll, 1998). 
Demographic regression equations employ an actuarial approach to the 
estimation of premorbid ability, using known relationships between demographic 
variables and performance on intelligence testing. Variables such as age, 
education and occupation are entered into a regression formula to yield a 
predicted "IQ" score. One advantage of utilising this method is that data is 
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gained without the need for testing and is independent of the person’s current 
cognitive functioning, thus remaining constant throughout an individual’s 
lifespan. However, some studies (e.g. Rentz et al., 2004) have demonstrated 
indices such as education are not always the most accurate estimation of IQ, 
perhaps as they do not account for intellectual development that may continue 
throughout life. There are also concerns regarding the accuracy of self-
reporting. 
Accuracy is limited in all approaches, as shown by Griffin el al. (2002) who, in 
his comparison of methods for predicting IQ, discovered reading tests and 
demographic equations systematically under or over-estimated IQ. These 
limitations pose significant challenges for clinicians who require accurate 
estimations in order to assess the extent of cognitive decline in patients with a 
dementia. Research in this area continues in order to equip clinicians with the 
best available evidence regarding the relative strengths and weaknesses of 
individual and combined approaches and regarding new tests available. 
Although reading ability has consistently been demonstrated to be preserved in 
the early stages of dementia (e.g. McGurn et al, 2004), McFarlane, Welch and 
Rodgers (2006) found a demographic estimation (based on a regression 
equation) and a lexical decision-making task (“Spot the Word” test) provided a 
higher estimate than the National Adult Reading Test (NART) for participants 
with mild Alzheimer’s.  The study also found that the Wechsler Test of Adult 
Reading (WTAR) was more robust than the NART, however it did 
underestimate IQ in participants with mild Alzheimer’s. 
The Test of Premorbid Functioning (TOPF) was developed by Wechsler in 2011 
and is an updated version of the WTAR. The TOPF is standardised with the 
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Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV). As the TOPF is a 
relatively new test there has yet to be any study conducted to assess its 
performance as a reading test against the other forms of estimating premorbid 
intelligence levels.  
 
Aims and hypotheses  
The principle aim of this study is to provide a follow-up to McFarlane, Welch and 
Roger’s (2006) study, exploring the robustness of the relatively new TOPF and 
STW-2 against a demographic estimate (based on a regression equation). The 
new measures will be explored in the context of Alzheimer’s dementia (AD), 
Vascular dementia (VD) and mixed Alzheimer’s and Vascular dementia (AVD). 
As it is well documented (e.g. Taylor, 1999; Cockburn et al., 2000) that reading 
ability becomes compromised with increasing severity of dementia, the study 
will focus on those with mild/moderate dementias. 
 
The primary hypothesis for this study is: 
Participants with a dementia will have significantly lower scaled scores 
on a reading test of pre-morbid ability (TOPF) than healthy controls. 
Secondary hypotheses are: 
1) Participants with a dementia will have significantly lower scaled scores 
on the TOPF than STW-2; 
2) There will be no more than a medium effect size difference between the 
scaled scores for participants with a dementia compared with the healthy 
control group on the STW-2; and 
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3) The discrepancy between a demographic based estimate of pre-morbid 
IQ and estimates derived from tests of reading ability will be significantly 
greater for those with dementias than healthy controls.  
 
Plan of Investigation  
 
Participants 
Participants with a diagnosis of probable AD, VD and AVD will be recruited from 
within two NHS Older Adult Community Mental Health teams. All participants 
will have been given a diagnosis by a psychiatrist using ICD-10 criteria. A 
healthy control group will be recruited from the partners of the participants with 
a dementia diagnosis, which will provide a match for age and socioeconomic 
status. Should the person with dementia not have a partner, or if the partner 
does not wish to or is unable to participate, this will not exclude the person with 
dementia from participating. In the event there are too few participants in the 
healthy control group, NHS staff will identify other potential participants and a 
pathway has been developed for this recruitment. Where partners attend 
appointments with the person with dementia, staff can approach these partners 
directly. For NHS patients whose partners don’t attend appointments, NHS staff 
can provide the patient with information to take home to their partner. Where 
possible, partners will be identified who are similar in age and socioeconomic 
status to those participants in the dementia group whose partner did not 
participate. 
  
Inclusion and Exclusion Criteria  
Inclusion criteria will include participants (up to the age of 84) with a diagnosis 
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of probable AD, VD and AVD (mild to moderate) and their partners. The age 
cut-off of 84 was chosen as this is the maximum age for the STW-2 normative 
data (the TOPF being 89). Participants will be recruited into the dementia group 
if their score on the Addenbrooke’s Cognitive Examination III (ACE-III) is 75 or 
below; their partners will be recruited into the healthy group if their ACE-III score 
is 88 or above (see Appendix A for explanation of score ranges). 
 
Exclusion criteria will be participants who  
 have visual or auditory difficulties (which cannot be corrected with the 
use of glasses or hearing aids);  
 a history of stroke, head injury or chronic alcohol use (where this has 
lead to a degree of aphasia); 
 have a diagnosed or suspected learning difficulty such as dyslexia; 
 those whose first language is not English; and 
 those with other types of dementia or where their dementia has resulted 
in aphasia 
 
Recruitment Procedures  
Potential participants will be given written information about the study via their 
psychiatrist, CPN or Link Worker, as part of the twelve-month post diagnostic 
support offered to all newly diagnosed patients (Scottish Government, 2013). If 
interested, they will complete the opt-in slip (consenting to be contacted) with 
the clinician who will send this to the researcher. They will then be provided with 
further written information about the study. The researcher will then contact the 
potential participants who will be provided with the opportunity to discuss the 
study further and ask questions. If potential participants agree to participate, 
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they be will be asked to sign a consent form. All information provided will be in 
size 16 font to ensure ease of reading for those with visual impairments. 
 
Measures  
The Test of Premorbid Functioning (TOPF) is a short reading test which 
provides an estimation of intelligence and is the revised and updated version of 
the Wechsler Test of Adult Reading (WTAR). As reading ability is thought to be 
preserved in early dementia, the test is utilised in clinical practice to assess 
premorbid intelligence levels in people with a diagnosed or suspected dementia. 
The test is comprised of 70 words with irregular grapheme to phoneme 
translations, making pronunciation difficult without previous familiarity.  
 
The Spot-The-Word (second edition) test estimates premorbid intelligence 
through the use of a lexical decision task. Individuals are presented with pairs of 
items comprising one real word and one nonsense word and are required to 
identify the real word. Individuals are not required to pronounce the words, 
merely point out the real words, thus requiring familiarity but not necessarily the 
ability to pronounce correctly.  
 
The ACE-III is a brief cognitive screening tool which can identify signs of 
cognitive decline. The tool assesses attention, memory, verbal fluency, 
language and visuospatial abilities. Scored out of 100, healthy individuals are 
expected to score 88 or above; below this score is indicative of cognitive 
decline. Participants with a dementia will be included if their ACE-III score is 75 
or below and their partners will be included if their ACE-III score is 88 or above. 
Explanation for these ranges can be found in Appendix A. Such ranges are 
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required in this study in order to ensure only participants with a definite 
dementia are included, and that the “healthy” group are indeed free from any 
neurodegenerative disease.  
 
All participants will be administered the ACE-III, TOPF and the STW-2 test. If a 
participant has already completed any of these within the last six months, 
permission will be sought to use those results.  
 
Design  
In this cross sectional study there will be two groups (a healthy group and a 
dementia group) of participants each of whom will be assessed on three 
measures of premorbid ability (TOPF, STW-2 and demographic equation). 
There will be a comparison of the discrepancies in scores between these 
groups on the measures. Demographic information will be sought from all 
participants including age, gender, years of education, occupational status and 
level of socioeconomic deprivation, which will be determined using the Scottish 
Index of Multiple Deprivation (SIMD). The SIMD measures deprivation in terms 
of employment, income, heath, education, access to services, crime, and 
housing and assigns each postcode a ranked score based on these factors. 
 
Although there is some risk of misclassification, all participants will be asked for 
their years of education and occupational status (or previous occupation if 
retired) and compare these with the results of the SIMD. Furthermore, due to 
the generation of participants being investigated, it is less likely that issues of 
social mobility will influence the results. Previous studies (e.g. Crawford & Allan, 
1997; Crawford et al, 1989) suggest participants should be credited with 0.5 
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years of education for every year of part-time education (which led or was 
leading to a formal qualification), which will be used in this study. 
 
Data analysis 
Independent t-tests will be used for comparing the discrepancy scores of the 
groups.  The groups will be matched on variables such as age, socioeconomic 
status (etc) through recruiting partners as the healthy group. Although this is not 
guaranteed to provide an exact match for all variables, this study is interested in 
the discrepancy scores between different measures and this will be evident (if 
present) regardless of any demographic differences. 
 
A multiple regression analysis will be used to predict participants’ premorbid 
intelligence based on demographic information and will be compared against 
scores on the TOPF and STW-2. The demographic equation will be entered into 
Crawford and Allan’s (1997) regression equation: 
Predicted FSIQ = 87.14 – (5.21 x occupation) + (1.78 x years of education) + 
(0.18 x age) 
In line with the regression equation, “occupation” will be classified into 5 
categories: 1 = professional; 2 = intermediate; 3 = skilled; 4 = semi-skilled; and 
5 = unskilled. Individuals who are retired, unemployed or who are 
housewives/husbands will be categorised according to their previous 
occupation. Those who have never worked will be classified as unskilled (code 
5).  
 
Updated regression equations have not been published to convert TOPF- 
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estimated IQ to the newer normative samples of the WAIS-IV, however 
Crawford and Allan’s (1997) equation was utilised in McFarlane, Welsh and 
Rodgers (2006) study.  
 
Secondary analyses will be conducted on the main hypotheses by comparing 
the results of those with a diagnosis of a dementia of the Alzheimer’s type and 
those with a diagnosis of vascular dementia. Furthermore, there will be an 
exploration as to whether different combinations of results (performance tests 
plus demographic variables) provide a better estimation of IQ, in terms of 
providing a better match with the control group. 
 
Justification of sample size 
When comparing performance of people with mild dementia and healthy 
controls, McFarlane et al. (2006) examined three different reading based 
measures and the average effect size of the differences between these groups 
was d=0.67 (medium-large). This was therefore used as the basis for estimating 
the sample size for the proposed study. In the proposed study independent t-
tests will compare the two groups (healthy controls and dementia groups), 
hence the effect size measure used as Cohen’s d (for which a medium-large 
size is d = 0.6). A “G-power” analysis confirmed that 72 participants (36 per 
group) will be required, based on the following: 
 effect size of d = 0.6  
 alpha level of 0.05 
 power level of 0.8 
Within the NHS sites identified (see below), the number of newly diagnosed 
(with dementia) patients per quarter ranges from 100 to 150 per quarter (i.e. 
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three months). Patients with Alzheimer’s dementia who are commenced on a 
cognitive enhancer medication are monitored within the service for a minimum 
of six weeks and, if the enhancer is to be continued, are monitored thereafter 
every six months. All patients diagnosed with a dementia, regardless of whether 
medication is prescribed, are also offered 12 months post-diagnostic support 
from the NHS team.  
 
Therefore recruiting 36 participants with a dementia and 36 partners from 
people with a dementia from a pool of patients conservatively estimated at 200 
should be feasible. This is estimate is based on 100 newly diagnosed people 
per quarter (thus 400 in a 12-month period) and half of these continuing to 
receive input from the NHS team in some capacity (i.e. medication reviews or 
psychosocial support).  
 
Settings and Equipment  
Participants will be seen in NHS clinics whenever possible and permission has 
been granted to conduct home visits, due to the population being studied. The 
clinics will be NHS Greater Glasgow and Clyde Older Adults Community Mental 
Health clinics. There will be two sites included in the study which will be 
Eastwood Resource Centre and Park View Resource Centre.  
 
Equipment required will be paper, and recording forms for the ACE-III, TOPF, 
STW-2. SPSS (v19) will be used for the analyses and a University of Glasgow 
encrypted laptop with the SPSS license will be sourced. 
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Health and Safety Issues 
 
Where participants are seen in an NHS clinic, there will be minimal health and 
safety issues for either researcher or participants. However, due to the 
population being studied, issues of mobility and transport difficulties are 
common, and standard clinical practice involves staff conducting home visits in 
order to provide an equitable service. Therefore, permission has been granted 
to offer home visits where necessary in order to allow people with such 
difficulties to still participate. All participants requiring a home visit will have 
been thoroughly risk assessed by trained staff in the community mental health 
teams. Local and national policy guidelines on health and safety and 
emergency procedures (e.g. lone working policy, fire safety) will be sought. 
Where lone visits are conducted, appropriate measures to ensure safety will be 
implemented, such as ensuring the NHS clinic has a record of the name and 
address of participant(s) being visited and at what time, the use of a fully 
charged mobile phone which the clinic has the number for, providing the clinic 
with a time when the visit should be completed by and ringing the office when 
the visit is completed. In the event that the researcher does not contact the 
clinic by the specified time, an administrator at the clinic will contact the 
researcher by mobile. The administrator will also have the contact telephone 
number of the participant(s) in the event the mobile telephone is not working 
(e.g. due to a lack of signal). A health and safety assessment form is included in 
Appendix B. A separate pathway has been developed for dealing with any 
concerns regarding risk for any participants in the study. 
 
Ethical Issues  
Issues of consent and capacity will need careful judgement. Psychiatrists 
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responsible for the potential participant’s care will be consulted as to capacity to 
consent. All participants will be checked for consent on the day of assessment. 
As this study is only recruiting patients with mild/moderate AD/VD/AVD, this 
should minimise difficulties with capacity to consent in participating. However, 
where the researcher is unsure, this will be addressed through discussion with 
the relevant psychiatrist. Where doubt remains, the participant will not be 
recruited or results not included. 
 
Recruiting healthy controls carries the risk of detecting cognitive difficulties 
which the participant was previously unaware of. Participants will be made 
aware of this prior to participating and will be given the option of discussing their 
results or not. Where the participant has any concerns regarding their test 
performance, this will be discussed and the participant will be directed to their 
G.P.  
 
No patient identifiable information will be sought and all information recorded 
will be on a university encrypted laptop. The data will be backed up on an 
encrypted memory stick. Paper copies of completed tests and consent forms 
will be stored in accordance with local and national Data Protection guidelines, 
and will be stored in a locked filing cabinet within NHS premises. The 
researcher and Chief Investigator will have access to the data and upon 
completion of the study, the Chief Investigator will retain the data. This will be 
held within the Institute of Mental Health and Wellbeing at the University of 
Glasgow (Gartnaval Royal Hospital) for ten years. Paper files containing 
personal information used to contact participants (e.g. name, address) will be 
destroyed by shredding upon the completion of study.   
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There will be an application to the NHS Research Ethics Committee who will 
provide feedback on plans to minimise any adverse effects on participants. 
 
Financial issues 
 
The main bulk of costs involved will be the purchase of the recording forms for 
the TOPF and STW-2. Full costs are given in Appendix C. 
 
Timetable 
 
Information to OA teams  November 2014 
Recruitment of participants November 2014 – January 2015 
Data collection January 2015 – May 2015 
Analysis and write-up May 2015 
Final write-up and preparation for viva June – July 2015 
 
 
Practical Applications  
The use of reading tests is popular in neuropsychological assessment, which 
aims to provide a cognitive profile, based on current and premorbid ability. If the 
TOPF does not provide an accurate estimate of premorbid functioning then this 
may have implications for its clinical use. This study aims to add to the evidence 
base by providing up-to-date evidence of the robustness of this new measure 
as well as the STW-2. Furthermore, should a combined approach (i.e. 
performance tests plus demographic variables) prove more effective than 
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performance tests alone, this will provide useful information for clinicians 
practising in the field. 
 
Dissemination of results 
Once the thesis is completed it will be submitted to the University of Glasgow as 
part fulfilment of the award of Doctorate in Clinical Psychology. The researcher 
will explore appropriate academic journals with the academic supervisor and 
submit for publication. Participants will be given the option of receiving a 
summary sheet of the findings of the study. This will be discussed with them 
when the researcher completes the consent form.
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